WO2022124201A1 - Sheet-like cosmetic - Google Patents
Sheet-like cosmetic Download PDFInfo
- Publication number
- WO2022124201A1 WO2022124201A1 PCT/JP2021/044343 JP2021044343W WO2022124201A1 WO 2022124201 A1 WO2022124201 A1 WO 2022124201A1 JP 2021044343 W JP2021044343 W JP 2021044343W WO 2022124201 A1 WO2022124201 A1 WO 2022124201A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sheet
- acid
- cosmetic according
- salt
- shaped cosmetic
- Prior art date
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 44
- 239000004721 Polyphenylene oxide Substances 0.000 claims abstract description 31
- 229920000570 polyether Polymers 0.000 claims abstract description 31
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 29
- 230000002087 whitening effect Effects 0.000 claims abstract description 27
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000004745 nonwoven fabric Substances 0.000 claims abstract description 17
- -1 ascorbic acid glucoside Chemical class 0.000 claims description 106
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 41
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 33
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 33
- 239000000194 fatty acid Substances 0.000 claims description 33
- 229930195729 fatty acid Natural products 0.000 claims description 33
- 239000004359 castor oil Substances 0.000 claims description 22
- 235000019438 castor oil Nutrition 0.000 claims description 22
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 22
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 claims description 20
- 229960005070 ascorbic acid Drugs 0.000 claims description 19
- 239000000835 fiber Substances 0.000 claims description 18
- 229920001577 copolymer Polymers 0.000 claims description 14
- 229920002125 Sokalan® Polymers 0.000 claims description 11
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 9
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 9
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 9
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 claims description 8
- 229940105990 diglycerin Drugs 0.000 claims description 7
- 229940008099 dimethicone Drugs 0.000 claims description 7
- 229930182478 glucoside Natural products 0.000 claims description 7
- 235000010323 ascorbic acid Nutrition 0.000 claims description 6
- 239000011668 ascorbic acid Substances 0.000 claims description 6
- YRJKYHIIYRGTCC-UHFFFAOYSA-M potassium;2-hydroxy-4-methoxybenzoate Chemical group [K+].COC1=CC=C(C([O-])=O)C(O)=C1 YRJKYHIIYRGTCC-UHFFFAOYSA-M 0.000 claims description 5
- 229920000728 polyester Polymers 0.000 claims description 4
- 229940016593 peg-20 glyceryl isostearate Drugs 0.000 claims description 3
- 230000001603 reducing effect Effects 0.000 abstract description 7
- 239000002585 base Substances 0.000 description 38
- 239000000843 powder Substances 0.000 description 37
- 239000003921 oil Substances 0.000 description 17
- 235000019198 oils Nutrition 0.000 description 17
- 238000000034 method Methods 0.000 description 16
- 229920003169 water-soluble polymer Polymers 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 239000002211 L-ascorbic acid Substances 0.000 description 13
- 235000000069 L-ascorbic acid Nutrition 0.000 description 13
- 238000011156 evaluation Methods 0.000 description 13
- 150000004665 fatty acids Chemical class 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 239000004166 Lanolin Substances 0.000 description 12
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 12
- 150000001298 alcohols Chemical class 0.000 description 12
- 235000019388 lanolin Nutrition 0.000 description 12
- 229940039717 lanolin Drugs 0.000 description 12
- 150000003839 salts Chemical class 0.000 description 12
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 12
- 238000002156 mixing Methods 0.000 description 11
- 125000002947 alkylene group Chemical group 0.000 description 10
- 229960000401 tranexamic acid Drugs 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- 239000010445 mica Substances 0.000 description 9
- 229910052618 mica group Inorganic materials 0.000 description 9
- 239000005056 polyisocyanate Substances 0.000 description 9
- 229920001228 polyisocyanate Polymers 0.000 description 9
- 229920005862 polyol Polymers 0.000 description 9
- 229920001296 polysiloxane Polymers 0.000 description 9
- 239000005057 Hexamethylene diisocyanate Substances 0.000 description 8
- 125000004432 carbon atom Chemical group C* 0.000 description 8
- 150000003077 polyols Chemical class 0.000 description 8
- 150000002148 esters Chemical class 0.000 description 7
- 239000003925 fat Substances 0.000 description 7
- 235000019197 fats Nutrition 0.000 description 7
- 239000001993 wax Substances 0.000 description 7
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- AWMVMTVKBNGEAK-UHFFFAOYSA-N Styrene oxide Chemical compound C1OC1C1=CC=CC=C1 AWMVMTVKBNGEAK-UHFFFAOYSA-N 0.000 description 6
- 125000005442 diisocyanate group Chemical group 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 238000006116 polymerization reaction Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000004408 titanium dioxide Substances 0.000 description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 5
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 125000000217 alkyl group Chemical group 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 150000002430 hydrocarbons Chemical group 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 4
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 4
- 235000019482 Palm oil Nutrition 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 235000015278 beef Nutrition 0.000 description 4
- 230000002950 deficient Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 4
- 229920000591 gum Polymers 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000002540 palm oil Substances 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 229920000139 polyethylene terephthalate Polymers 0.000 description 4
- 239000005020 polyethylene terephthalate Substances 0.000 description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 3
- MRIXVKKOHPQOFK-UHFFFAOYSA-N 4-methoxysalicylic acid Chemical compound COC1=CC=C(C(O)=O)C(O)=C1 MRIXVKKOHPQOFK-UHFFFAOYSA-N 0.000 description 3
- IZZIWIAOVZOBLF-UHFFFAOYSA-N 5-methyloxysalicylic acid Natural products COC1=CC=C(O)C(C(O)=O)=C1 IZZIWIAOVZOBLF-UHFFFAOYSA-N 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical group C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 125000000753 cycloalkyl group Chemical group 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical group FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 3
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 238000005470 impregnation Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000012948 isocyanate Substances 0.000 description 3
- 150000002513 isocyanates Chemical class 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 229920001451 polypropylene glycol Polymers 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 230000003068 static effect Effects 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- ARXKVVRQIIOZGF-UHFFFAOYSA-N 1,2,4-butanetriol Chemical compound OCCC(O)CO ARXKVVRQIIOZGF-UHFFFAOYSA-N 0.000 description 2
- LUYHWJKHJNFYGV-UHFFFAOYSA-N 1,2-diisocyanato-3-phenylbenzene Chemical compound O=C=NC1=CC=CC(C=2C=CC=CC=2)=C1N=C=O LUYHWJKHJNFYGV-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- JVTIXNMXDLQEJE-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate 2-octanoyloxypropyl octanoate Chemical compound C(CCCCCCC)(=O)OCC(C)OC(CCCCCCC)=O.C(=O)(CCCCCCCCC)OCC(C)OC(=O)CCCCCCCCC JVTIXNMXDLQEJE-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- AUZQQIPZESHNMG-UHFFFAOYSA-N 3-methoxysalicylic acid Chemical compound COC1=CC=CC(C(O)=O)=C1O AUZQQIPZESHNMG-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 2
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 2
- 229920000161 Locust bean gum Polymers 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical class [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 2
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 2
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 238000012644 addition polymerization Methods 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 125000002877 alkyl aryl group Chemical group 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- IMHDGJOMLMDPJN-UHFFFAOYSA-N biphenyl-2,2'-diol Chemical compound OC1=CC=CC=C1C1=CC=CC=C1O IMHDGJOMLMDPJN-UHFFFAOYSA-N 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000010696 ester oil Substances 0.000 description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 2
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical class OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- 229940100463 hexyl laurate Drugs 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 235000010420 locust bean gum Nutrition 0.000 description 2
- 239000000711 locust bean gum Substances 0.000 description 2
- 229910052749 magnesium Chemical class 0.000 description 2
- 239000011777 magnesium Chemical class 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 235000021313 oleic acid Nutrition 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical group OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 229940031439 squalene Drugs 0.000 description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- UUJLHYCIMQOUKC-UHFFFAOYSA-N trimethyl-[oxo(trimethylsilylperoxy)silyl]peroxysilane Chemical compound C[Si](C)(C)OO[Si](=O)OO[Si](C)(C)C UUJLHYCIMQOUKC-UHFFFAOYSA-N 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- VBURMNYQYXSQEL-VFAVKCLXSA-N (2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one (Z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O VBURMNYQYXSQEL-VFAVKCLXSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- IRVNEGRHQKGRGD-WPXUHFOISA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;hexadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O IRVNEGRHQKGRGD-WPXUHFOISA-N 0.000 description 1
- PBTPTBMYJPCXRQ-MGMRMFRLSA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;hexadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O PBTPTBMYJPCXRQ-MGMRMFRLSA-N 0.000 description 1
- MHUOEHQATDLJFZ-WPXUHFOISA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;octadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O MHUOEHQATDLJFZ-WPXUHFOISA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical class C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- RUHCWQAFCGVQJX-RVWHZBQESA-N (3s,8s,9s,10r,13r,14s,17r)-3-hydroxy-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-1-one Chemical compound C1C=C2C[C@H](O)CC(=O)[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 RUHCWQAFCGVQJX-RVWHZBQESA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- VNMOIBZLSJDQEO-UHFFFAOYSA-N 1,10-diisocyanatodecane Chemical compound O=C=NCCCCCCCCCCN=C=O VNMOIBZLSJDQEO-UHFFFAOYSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- NNOZGCICXAYKLW-UHFFFAOYSA-N 1,2-bis(2-isocyanatopropan-2-yl)benzene Chemical compound O=C=NC(C)(C)C1=CC=CC=C1C(C)(C)N=C=O NNOZGCICXAYKLW-UHFFFAOYSA-N 0.000 description 1
- FKTHNVSLHLHISI-UHFFFAOYSA-N 1,2-bis(isocyanatomethyl)benzene Chemical class O=C=NCC1=CC=CC=C1CN=C=O FKTHNVSLHLHISI-UHFFFAOYSA-N 0.000 description 1
- ZTNJGMFHJYGMDR-UHFFFAOYSA-N 1,2-diisocyanatoethane Chemical compound O=C=NCCN=C=O ZTNJGMFHJYGMDR-UHFFFAOYSA-N 0.000 description 1
- ZXHZWRZAWJVPIC-UHFFFAOYSA-N 1,2-diisocyanatonaphthalene Chemical compound C1=CC=CC2=C(N=C=O)C(N=C=O)=CC=C21 ZXHZWRZAWJVPIC-UHFFFAOYSA-N 0.000 description 1
- IKYNWXNXXHWHLL-UHFFFAOYSA-N 1,3-diisocyanatopropane Chemical compound O=C=NCCCN=C=O IKYNWXNXXHWHLL-UHFFFAOYSA-N 0.000 description 1
- ALQLPWJFHRMHIU-UHFFFAOYSA-N 1,4-diisocyanatobenzene Chemical compound O=C=NC1=CC=C(N=C=O)C=C1 ALQLPWJFHRMHIU-UHFFFAOYSA-N 0.000 description 1
- OVBFMUAFNIIQAL-UHFFFAOYSA-N 1,4-diisocyanatobutane Chemical compound O=C=NCCCCN=C=O OVBFMUAFNIIQAL-UHFFFAOYSA-N 0.000 description 1
- SBJCUZQNHOLYMD-UHFFFAOYSA-N 1,5-Naphthalene diisocyanate Chemical compound C1=CC=C2C(N=C=O)=CC=CC2=C1N=C=O SBJCUZQNHOLYMD-UHFFFAOYSA-N 0.000 description 1
- DFPJRUKWEPYFJT-UHFFFAOYSA-N 1,5-diisocyanatopentane Chemical compound O=C=NCCCCCN=C=O DFPJRUKWEPYFJT-UHFFFAOYSA-N 0.000 description 1
- GHSZVIPKVOEXNX-UHFFFAOYSA-N 1,9-diisocyanatononane Chemical compound O=C=NCCCCCCCCCN=C=O GHSZVIPKVOEXNX-UHFFFAOYSA-N 0.000 description 1
- UAFHRUBCOQPFFM-UHFFFAOYSA-N 1-(aminomethyl)cyclohexane-1-carboxylic acid Chemical compound NCC1(C(O)=O)CCCCC1 UAFHRUBCOQPFFM-UHFFFAOYSA-N 0.000 description 1
- FJGNTEKSQVNVTJ-UHFFFAOYSA-N 1-Deoxy-D-ribitol Chemical compound CC(O)C(O)C(O)CO FJGNTEKSQVNVTJ-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- RMSGQZDGSZOJMU-UHFFFAOYSA-N 1-butyl-2-phenylbenzene Chemical group CCCCC1=CC=CC=C1C1=CC=CC=C1 RMSGQZDGSZOJMU-UHFFFAOYSA-N 0.000 description 1
- AXIWPQKLPMINAT-UHFFFAOYSA-N 1-ethyl-2,3-diisocyanatobenzene Chemical compound CCC1=CC=CC(N=C=O)=C1N=C=O AXIWPQKLPMINAT-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- DHGBAFGZLVRESL-UHFFFAOYSA-N 14-methylpentadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C DHGBAFGZLVRESL-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical class C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- ZTBHEZIOGARBOD-UHFFFAOYSA-N 2,3,4-trimethylpentane-2,3,4-triol Chemical compound CC(C)(O)C(C)(O)C(C)(C)O ZTBHEZIOGARBOD-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 1
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 1
- AIUFBIQURVCZNA-UHFFFAOYSA-N 2,4-dimethylpentane-2,3,4-triol Chemical compound CC(C)(O)C(O)C(C)(C)O AIUFBIQURVCZNA-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 1
- DJXPNUIRGNRCPQ-UHFFFAOYSA-N 2-[2,3-bis[2-(16-methylheptadecanoyloxy)ethoxy]propoxy]ethyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCOCC(COCCOC(=O)CCCCCCCCCCCCCCC(C)C)OCCOC(=O)CCCCCCCCCCCCCCC(C)C DJXPNUIRGNRCPQ-UHFFFAOYSA-N 0.000 description 1
- TXBCBTDQIULDIA-UHFFFAOYSA-N 2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(CO)(CO)COCC(CO)(CO)CO TXBCBTDQIULDIA-UHFFFAOYSA-N 0.000 description 1
- HEGVMQRLACCEDT-UHFFFAOYSA-N 2-ethylbutane-1,2,3-triol Chemical compound CCC(O)(CO)C(C)O HEGVMQRLACCEDT-UHFFFAOYSA-N 0.000 description 1
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- OGJDIJKJFYOENF-UHFFFAOYSA-N 2-hexyldecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC OGJDIJKJFYOENF-UHFFFAOYSA-N 0.000 description 1
- JUIYTAQAHOONSH-UHFFFAOYSA-N 2-hydroxy-4-propan-2-yloxybenzoic acid Chemical compound CC(C)OC1=CC=C(C(O)=O)C(O)=C1 JUIYTAQAHOONSH-UHFFFAOYSA-N 0.000 description 1
- IXKMJGZLCSWMTD-UHFFFAOYSA-N 2-hydroxy-4-propoxybenzoic acid Chemical compound CCCOC1=CC=C(C(O)=O)C(O)=C1 IXKMJGZLCSWMTD-UHFFFAOYSA-N 0.000 description 1
- AAUQLHHARJUJEH-UHFFFAOYSA-N 2-hydroxy-5-methoxybenzoic acid Natural products COC1=CC=CC(O)=C1C(O)=O AAUQLHHARJUJEH-UHFFFAOYSA-N 0.000 description 1
- VHCJSVNQEBEVMO-UHFFFAOYSA-N 2-hydroxy-5-propoxybenzoic acid Chemical compound CCCOC1=CC=C(O)C(C(O)=O)=C1 VHCJSVNQEBEVMO-UHFFFAOYSA-N 0.000 description 1
- OOJRTGIXWIUBGG-UHFFFAOYSA-N 2-methylpropane-1,2,3-triol Chemical compound OCC(O)(C)CO OOJRTGIXWIUBGG-UHFFFAOYSA-N 0.000 description 1
- XATHTZNVYDUDGS-UHFFFAOYSA-N 2-octadecylpropane-1,2,3-triol Chemical compound CCCCCCCCCCCCCCCCCCC(O)(CO)CO XATHTZNVYDUDGS-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- MSPJNHHBNOLHOC-UHFFFAOYSA-N 3,3-dimethylcyclopropane-1,2-dicarboxylic acid Chemical compound CC1(C)C(C(O)=O)C1C(O)=O MSPJNHHBNOLHOC-UHFFFAOYSA-N 0.000 description 1
- ZGSCRDSBTNQPMS-UJURSFKZSA-N 3-O-Ethylascorbic acid Chemical compound CCOC1=C(O)C(=O)O[C@@H]1[C@@H](O)CO ZGSCRDSBTNQPMS-UJURSFKZSA-N 0.000 description 1
- VHDMXHLHMMROPO-UHFFFAOYSA-N 3-deoxypentitol Chemical compound OCC(O)CC(O)CO VHDMXHLHMMROPO-UHFFFAOYSA-N 0.000 description 1
- PKYUNJWBVAXPMG-UHFFFAOYSA-N 3-ethoxy-2-hydroxybenzoic acid Chemical compound CCOC1=CC=CC(C(O)=O)=C1O PKYUNJWBVAXPMG-UHFFFAOYSA-N 0.000 description 1
- QFZITDCVRJQLMZ-UHFFFAOYSA-N 3-methylbutane-1,2,3-triol Chemical compound CC(C)(O)C(O)CO QFZITDCVRJQLMZ-UHFFFAOYSA-N 0.000 description 1
- 229940120145 3-o-ethylascorbic acid Drugs 0.000 description 1
- GNKZMNRKLCTJAY-UHFFFAOYSA-N 4'-Methylacetophenone Chemical compound CC(=O)C1=CC=C(C)C=C1 GNKZMNRKLCTJAY-UHFFFAOYSA-N 0.000 description 1
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 description 1
- ZQXRINMCMHCYBD-UHFFFAOYSA-N 4-(2-ethylhexoxy)-4-oxobutanoic acid Chemical compound CCCCC(CC)COC(=O)CCC(O)=O ZQXRINMCMHCYBD-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- JBRMEFWJFBHUKG-UHFFFAOYSA-N 4-[(diaminomethylideneamino)methyl]cyclohexane-1-carboxylic acid Chemical compound NC(N)=NCC1CCC(C(O)=O)CC1 JBRMEFWJFBHUKG-UHFFFAOYSA-N 0.000 description 1
- RNGFVIMNTYOBTK-UHFFFAOYSA-N 4-butoxy-2-hydroxybenzoic acid Chemical compound CCCCOC1=CC=C(C(O)=O)C(O)=C1 RNGFVIMNTYOBTK-UHFFFAOYSA-N 0.000 description 1
- DVZPQHRWOUXUPU-UHFFFAOYSA-N 4-ethoxy-2-hydroxybenzoic acid Chemical compound CCOC1=CC=C(C(O)=O)C(O)=C1 DVZPQHRWOUXUPU-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- UQRONKZLYKUEMO-UHFFFAOYSA-N 4-methyl-1-(2,4,6-trimethylphenyl)pent-4-en-2-one Chemical group CC(=C)CC(=O)Cc1c(C)cc(C)cc1C UQRONKZLYKUEMO-UHFFFAOYSA-N 0.000 description 1
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 description 1
- FMYBGKLXXBSJKK-UHFFFAOYSA-N 4-propylheptane-3,4,5-triol Chemical compound CCCC(O)(C(O)CC)C(O)CC FMYBGKLXXBSJKK-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- ZZKFPIOJAOEMQL-UHFFFAOYSA-N 5-ethoxy-2-hydroxybenzoic acid Chemical compound CCOC1=CC=C(O)C(C(O)=O)=C1 ZZKFPIOJAOEMQL-UHFFFAOYSA-N 0.000 description 1
- GZVHEAJQGPRDLQ-UHFFFAOYSA-N 6-phenyl-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC(N)=NC(C=2C=CC=CC=2)=N1 GZVHEAJQGPRDLQ-UHFFFAOYSA-N 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- 229920002972 Acrylic fiber Polymers 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- BMFMQGXDDJALKQ-BYPYZUCNSA-N Argininic acid Chemical compound NC(N)=NCCC[C@H](O)C(O)=O BMFMQGXDDJALKQ-BYPYZUCNSA-N 0.000 description 1
- LITUBCVUXPBCGA-WMZHIEFXSA-N Ascorbyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O LITUBCVUXPBCGA-WMZHIEFXSA-N 0.000 description 1
- 235000012137 Atriplex confertifolia Nutrition 0.000 description 1
- 244000266618 Atriplex confertifolia Species 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- UEQVLKWMHAYVLO-MGCOHNPYSA-N C1C[C@@H](CN)CC[C@@H]1C(=O)OC1=CC=C(O)C=C1C(O)=O Chemical compound C1C[C@@H](CN)CC[C@@H]1C(=O)OC1=CC=C(O)C=C1C(O)=O UEQVLKWMHAYVLO-MGCOHNPYSA-N 0.000 description 1
- MAMABHFMIUQTIY-UHFFFAOYSA-N CC1=CC=CC=C1.N=C=O.N=C=O.N=C=O Chemical compound CC1=CC=CC=C1.N=C=O.N=C=O.N=C=O MAMABHFMIUQTIY-UHFFFAOYSA-N 0.000 description 1
- AVWTXYWHGFHGQD-ZKCHVHJHSA-N CNC(=O)[C@H]1CC[C@H](CN)CC1 Chemical compound CNC(=O)[C@H]1CC[C@H](CN)CC1 AVWTXYWHGFHGQD-ZKCHVHJHSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- VQAWRQZAAIQXHM-UHFFFAOYSA-N Cepharanthine Natural products O1C(C=C2)=CC=C2CC(C=23)N(C)CCC3=CC=3OCOC=3C=2OC(=CC=23)C(OC)=CC=2CCN(C)C3CC2=CC=C(O)C1=C2 VQAWRQZAAIQXHM-UHFFFAOYSA-N 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical compound CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 244000058871 Echinochloa crus-galli Species 0.000 description 1
- 235000008247 Echinochloa frumentacea Nutrition 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- PVNIQBQSYATKKL-UHFFFAOYSA-N Glycerol trihexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC PVNIQBQSYATKKL-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- SHBUUTHKGIVMJT-UHFFFAOYSA-N Hydroxystearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OO SHBUUTHKGIVMJT-UHFFFAOYSA-N 0.000 description 1
- 239000005058 Isophorone diisocyanate Substances 0.000 description 1
- KIENGQUGHPTFGC-JLAZNSOCSA-N L-ascorbic acid 6-phosphate Chemical class OP(=O)(O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O KIENGQUGHPTFGC-JLAZNSOCSA-N 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 229920000433 Lyocell Polymers 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000017822 Melilotus officinalis Nutrition 0.000 description 1
- 240000000366 Melilotus officinalis Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- OIHKYGKXCCDJLK-UHFFFAOYSA-N N=C=O.N=C=O.C1=CC=CC=C1C1=CC=CC=C1 Chemical class N=C=O.N=C=O.C1=CC=CC=C1C1=CC=CC=C1 OIHKYGKXCCDJLK-UHFFFAOYSA-N 0.000 description 1
- HDEAYPRXFHBTAS-UHFFFAOYSA-N N=C=O.N=C=O.CC(C)C1=CC=CC=C1 Chemical compound N=C=O.N=C=O.CC(C)C1=CC=CC=C1 HDEAYPRXFHBTAS-UHFFFAOYSA-N 0.000 description 1
- DCQSAIDAWCXJJG-UHFFFAOYSA-N N=C=O.N=C=O.CC(C)CC(C)(C)C Chemical compound N=C=O.N=C=O.CC(C)CC(C)(C)C DCQSAIDAWCXJJG-UHFFFAOYSA-N 0.000 description 1
- BKAKFCXOCHNIIP-UHFFFAOYSA-N N=C=O.N=C=O.CC1=CC=CC(C=2C=C(C)C=CC=2)=C1 Chemical compound N=C=O.N=C=O.CC1=CC=CC(C=2C=C(C)C=CC=2)=C1 BKAKFCXOCHNIIP-UHFFFAOYSA-N 0.000 description 1
- XOMPUFACNHSNPC-UHFFFAOYSA-N N=C=O.N=C=O.CC1=CC=CC=C1C Chemical compound N=C=O.N=C=O.CC1=CC=CC=C1C XOMPUFACNHSNPC-UHFFFAOYSA-N 0.000 description 1
- MFWSSBVVMCUQFC-UHFFFAOYSA-N N=C=O.N=C=O.CCCC(C)(C)C Chemical compound N=C=O.N=C=O.CCCC(C)(C)C MFWSSBVVMCUQFC-UHFFFAOYSA-N 0.000 description 1
- MSEUNUPDNUFZAR-UHFFFAOYSA-N N=C=O.N=C=O.CCCCOC(CC)CCC Chemical compound N=C=O.N=C=O.CCCCOC(CC)CCC MSEUNUPDNUFZAR-UHFFFAOYSA-N 0.000 description 1
- ZYLYYFJVVKPPEQ-UHFFFAOYSA-N N=C=O.N=C=O.CCCOCCC Chemical compound N=C=O.N=C=O.CCCOCCC ZYLYYFJVVKPPEQ-UHFFFAOYSA-N 0.000 description 1
- TYBHFANFHRQLPL-UHFFFAOYSA-N N=C=O.N=C=O.CCCOCCCCOCCC Chemical compound N=C=O.N=C=O.CCCOCCCCOCCC TYBHFANFHRQLPL-UHFFFAOYSA-N 0.000 description 1
- IMYJBPVLTJBMPO-UHFFFAOYSA-N N=C=O.N=C=O.COC1=CC=CC(C=2C=C(OC)C=CC=2)=C1 Chemical compound N=C=O.N=C=O.COC1=CC=CC(C=2C=C(OC)C=CC=2)=C1 IMYJBPVLTJBMPO-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- YQINWFJNFJEWHH-UCLHFMLVSA-N OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O YQINWFJNFJEWHH-UCLHFMLVSA-N 0.000 description 1
- GAKOHFNTEXOHTP-RXSVEWSESA-N OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.OP(O)(=O)OP(O)(=O)OP(O)(O)=O Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.OP(O)(=O)OP(O)(=O)OP(O)(O)=O GAKOHFNTEXOHTP-RXSVEWSESA-N 0.000 description 1
- 241000596467 Ononis Species 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 241001125046 Sardina pilchardus Species 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- 235000006732 Torreya nucifera Nutrition 0.000 description 1
- 244000111306 Torreya nucifera Species 0.000 description 1
- GYDJEQRTZSCIOI-UHFFFAOYSA-N Tranexamic acid Chemical compound NCC1CCC(C(O)=O)CC1 GYDJEQRTZSCIOI-UHFFFAOYSA-N 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 241000313631 Viola uliginosa Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 125000004450 alkenylene group Chemical group 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 229940072049 amyl acetate Drugs 0.000 description 1
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 125000001204 arachidyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 229940072065 ascorbic acid 2-sulfate Drugs 0.000 description 1
- 108010045569 atelocollagen Proteins 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 239000012179 bayberry wax Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- OHJMTUPIZMNBFR-UHFFFAOYSA-N biuret Chemical compound NC(=O)NC(N)=O OHJMTUPIZMNBFR-UHFFFAOYSA-N 0.000 description 1
- 239000001055 blue pigment Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 239000001058 brown pigment Substances 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- HRBZRZSCMANEHQ-UHFFFAOYSA-L calcium;hexadecanoate Chemical compound [Ca+2].CCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCC([O-])=O HRBZRZSCMANEHQ-UHFFFAOYSA-L 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 229940085237 carbomer-980 Drugs 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 229940075510 carbopol 981 Drugs 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 230000004098 cellular respiration Effects 0.000 description 1
- YVPXVXANRNDGTA-WDYNHAJCSA-N cepharanthine Chemical compound C1C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@H](C2=C3)N(C)CCC2=CC(OC)=C3OC2=C(OCO3)C3=CC3=C2[C@H]1N(C)CC3 YVPXVXANRNDGTA-WDYNHAJCSA-N 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- VQWFNAGFNGABOH-UHFFFAOYSA-K chromium(iii) hydroxide Chemical compound [OH-].[OH-].[OH-].[Cr+3] VQWFNAGFNGABOH-UHFFFAOYSA-K 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 125000000490 cinnamyl group Chemical group C(C=CC1=CC=CC=C1)* 0.000 description 1
- LFSBSHDDAGNCTM-UHFFFAOYSA-N cobalt(2+);oxygen(2-);titanium(4+) Chemical compound [O-2].[O-2].[O-2].[Ti+4].[Co+2] LFSBSHDDAGNCTM-UHFFFAOYSA-N 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- DNTGGZPQPQTDQF-XBXARRHUSA-N crotamiton Chemical compound C/C=C/C(=O)N(CC)C1=CC=CC=C1C DNTGGZPQPQTDQF-XBXARRHUSA-N 0.000 description 1
- 229960003338 crotamiton Drugs 0.000 description 1
- 125000002592 cumenyl group Chemical group C1(=C(C=CC=C1)*)C(C)C 0.000 description 1
- WZHCOOQXZCIUNC-UHFFFAOYSA-N cyclandelate Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C(O)C1=CC=CC=C1 WZHCOOQXZCIUNC-UHFFFAOYSA-N 0.000 description 1
- 229960000729 cyclandelate Drugs 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000000392 cycloalkenyl group Chemical group 0.000 description 1
- 125000005724 cycloalkenylene group Chemical group 0.000 description 1
- 125000002993 cycloalkylene group Chemical group 0.000 description 1
- 125000001162 cycloheptenyl group Chemical group C1(=CCCCCC1)* 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- ARUKYTASOALXFG-UHFFFAOYSA-N cycloheptylcycloheptane Chemical compound C1CCCCCC1C1CCCCCC1 ARUKYTASOALXFG-UHFFFAOYSA-N 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000003493 decenyl group Chemical group [H]C([*])=C([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- RCJVRSBWZCNNQT-UHFFFAOYSA-N dichloridooxygen Chemical compound ClOCl RCJVRSBWZCNNQT-UHFFFAOYSA-N 0.000 description 1
- 229940031769 diisobutyl adipate Drugs 0.000 description 1
- KIQKWYUGPPFMBV-UHFFFAOYSA-N diisocyanatomethane Chemical compound O=C=NCN=C=O KIQKWYUGPPFMBV-UHFFFAOYSA-N 0.000 description 1
- LIKFHECYJZWXFJ-UHFFFAOYSA-N dimethyldichlorosilane Chemical compound C[Si](C)(Cl)Cl LIKFHECYJZWXFJ-UHFFFAOYSA-N 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical group C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 125000005066 dodecenyl group Chemical group C(=CCCCCCCCCCC)* 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229960005219 gentisic acid Drugs 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940074052 glyceryl isostearate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 239000001056 green pigment Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- GQXQIRNPJBUEGY-UHFFFAOYSA-N hexadecan-7-yl 2,2-dimethyloctanoate Chemical compound CCCCCCCCCC(CCCCCC)OC(=O)C(C)(C)CCCCCC GQXQIRNPJBUEGY-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- NEXSMEBSBIABKL-UHFFFAOYSA-N hexamethyldisilane Chemical compound C[Si](C)(C)[Si](C)(C)C NEXSMEBSBIABKL-UHFFFAOYSA-N 0.000 description 1
- XKYZEKVVQZGXOJ-UHFFFAOYSA-N hexane-1,3,4,5-tetrol Chemical compound CC(O)C(O)C(O)CCO XKYZEKVVQZGXOJ-UHFFFAOYSA-N 0.000 description 1
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 description 1
- TZQPAZWGRJYTLN-UHFFFAOYSA-N hexane-2,3,4,5-tetrol Chemical compound CC(O)C(O)C(O)C(C)O TZQPAZWGRJYTLN-UHFFFAOYSA-N 0.000 description 1
- QPNQLFAXFXPMSV-UHFFFAOYSA-N hexane-2,3,4-triol Chemical compound CCC(O)C(O)C(C)O QPNQLFAXFXPMSV-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- 229940072106 hydroxystearate Drugs 0.000 description 1
- VVIUBCNYACGLLV-UHFFFAOYSA-N hypotaurine Chemical compound [NH3+]CCS([O-])=O VVIUBCNYACGLLV-UHFFFAOYSA-N 0.000 description 1
- 229960005436 inositol nicotinate Drugs 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- JCDAAXRCMMPNBO-UHFFFAOYSA-N iron(3+);oxygen(2-);titanium(4+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Ti+4].[Ti+4].[Fe+3].[Fe+3] JCDAAXRCMMPNBO-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- 125000002510 isobutoxy group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])O* 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- NIMLQBUJDJZYEJ-UHFFFAOYSA-N isophorone diisocyanate Chemical compound CC1(C)CC(N=C=O)CC(C)(CN=C=O)C1 NIMLQBUJDJZYEJ-UHFFFAOYSA-N 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 125000002463 lignoceryl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 229910001947 lithium oxide Inorganic materials 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- KRDTUMQGDPZWMF-UHFFFAOYSA-N methyl 1-aminocyclohexane-1-carboxylate Chemical compound COC(=O)C1(N)CCCCC1 KRDTUMQGDPZWMF-UHFFFAOYSA-N 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- MFZCIDXOLLEMOO-GYSGTQPESA-N myo-inositol hexanicotinate Chemical compound O([C@H]1[C@@H]([C@H]([C@@H](OC(=O)C=2C=NC=CC=2)[C@@H](OC(=O)C=2C=NC=CC=2)[C@@H]1OC(=O)C=1C=NC=CC=1)OC(=O)C=1C=NC=CC=1)OC(=O)C=1C=NC=CC=1)C(=O)C1=CC=CN=C1 MFZCIDXOLLEMOO-GYSGTQPESA-N 0.000 description 1
- 125000001802 myricyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N nicotinic acid Natural products OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 1
- 125000005187 nonenyl group Chemical group C(=CCCCCCCC)* 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- UVPGECJLXBGLDW-UHFFFAOYSA-N octadecan-7-ol Chemical compound CCCCCCCCCCCC(O)CCCCCC UVPGECJLXBGLDW-UHFFFAOYSA-N 0.000 description 1
- 125000004365 octenyl group Chemical group C(=CCCCCCC)* 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 229940023750 peg-60 glyceryl isostearate Drugs 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- MOIOWCZVZKHQIC-UHFFFAOYSA-N pentane-1,2,4-triol Chemical compound CC(O)CC(O)CO MOIOWCZVZKHQIC-UHFFFAOYSA-N 0.000 description 1
- JJAIIULJXXEFLV-UHFFFAOYSA-N pentane-2,3,4-triol Chemical compound CC(O)C(O)C(C)O JJAIIULJXXEFLV-UHFFFAOYSA-N 0.000 description 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920006122 polyamide resin Polymers 0.000 description 1
- 229920000120 polyethyl acrylate Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920006306 polyurethane fiber Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000001057 purple pigment Substances 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 150000003333 secondary alcohols Chemical class 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 235000002316 solid fats Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052917 strontium silicate Inorganic materials 0.000 description 1
- QSQXISIULMTHLV-UHFFFAOYSA-N strontium;dioxido(oxo)silane Chemical compound [Sr+2].[O-][Si]([O-])=O QSQXISIULMTHLV-UHFFFAOYSA-N 0.000 description 1
- 125000005504 styryl group Chemical group 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 125000005063 tetradecenyl group Chemical group C(=CCCCCCCCCCCCC)* 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
- SHWIJIJNPFXOFS-UHFFFAOYSA-N thiotaurine Chemical compound NCCS(O)(=O)=S SHWIJIJNPFXOFS-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 description 1
- RUELTTOHQODFPA-UHFFFAOYSA-N toluene 2,6-diisocyanate Chemical compound CC1=C(N=C=O)C=CC=C1N=C=O RUELTTOHQODFPA-UHFFFAOYSA-N 0.000 description 1
- 125000005425 toluyl group Chemical group 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- LFXJGGDONSCPOF-UHFFFAOYSA-N trichloro(hexyl)silane Chemical class CCCCCC[Si](Cl)(Cl)Cl LFXJGGDONSCPOF-UHFFFAOYSA-N 0.000 description 1
- DOEHJNBEOVLHGL-UHFFFAOYSA-N trichloro(propyl)silane Chemical class CCC[Si](Cl)(Cl)Cl DOEHJNBEOVLHGL-UHFFFAOYSA-N 0.000 description 1
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- QXJQHYBHAIHNGG-UHFFFAOYSA-N trimethylolethane Chemical compound OCC(C)(CO)CO QXJQHYBHAIHNGG-UHFFFAOYSA-N 0.000 description 1
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 1
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- PBYZMCDFOULPGH-UHFFFAOYSA-N tungstate Chemical compound [O-][W]([O-])(=O)=O PBYZMCDFOULPGH-UHFFFAOYSA-N 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 125000005065 undecenyl group Chemical group C(=CCCCCCCCCC)* 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 239000012808 vapor phase Substances 0.000 description 1
- 229960001722 verapamil Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 125000005023 xylyl group Chemical group 0.000 description 1
- 239000001052 yellow pigment Substances 0.000 description 1
- 239000009538 yokuinin Substances 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 229940105125 zinc myristate Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- GBFLQPIIIRJQLU-UHFFFAOYSA-L zinc;tetradecanoate Chemical compound [Zn+2].CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O GBFLQPIIIRJQLU-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/87—Polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Definitions
- the present invention relates to a sheet-like cosmetic product impregnated with a base.
- Patent Document 1 describes skin cosmetics containing tranexamic acid or ascorbic acid glucoside.
- Patent Document 2 describes L-ascorbic acid 2-glucoside, 3-O-ethylascorbic acid, kodiic acid, ellagic acid, hydroquinone ⁇ -D-glucoside, 4-n-butylresorcinol, 5,5'-dipropyl.
- Described is a gel composition comprising biphenyl-2,2'-diol, cetyl tranexamic acid hydrochloride, trans-4- (aminomethyl) cyclohexanecarboxylic acid, nicotinic acid amide, and potassium 4-methoxysalicylic acid salt. ..
- Patent Document 3 describes a sheet-shaped cosmetic containing as an active ingredient a whitening ingredient such as tranexamic acid or 4-methoxysalicylic acid potassium salt, an anti-inflammatory ingredient and a moisturizing ingredient, and containing an alkaligenes-producing polysaccharide. ing.
- the present invention has been made in view of the above problems, and can contain a salt-type whitening agent without reducing the viscosity of the base, does not drip even when applied to the skin, and after peeling off the sheet.
- the purpose of the present invention is to provide a sheet-like cosmetic that has excellent stickiness and is not sticky after being peeled off even though the sheet has high adhesion to the skin.
- the sheet-shaped cosmetic of the present invention is at least, (A) Hydrophobic-modified polyether urethane and (B) Salt-type whitening agent and
- the non-woven fabric is impregnated with a base containing the above.
- the salt-type whitening agent is preferably 4-methoxysalicylic acid potassium salt or ascorbic acid glucoside.
- the mass ratio of (A) hydrophobically modified polyether urethane to (B) salt-type whitening agent is preferably 0.2 to 1.
- (D) polyoxyethylene fatty acid glyceryl or polyoxyethylene hydrogenated castor oil it is preferable to contain at least one of (D) polyoxyethylene fatty acid glyceryl or polyoxyethylene hydrogenated castor oil.
- the hydrophobically modified polyether urethane is preferably a (PEG-240 / decyltetradeceth-20 / HDI) copolymer.
- the (D) polyoxyethylene fatty acid glyceryl is preferably PEG-20 glyceryl (mono) isostearate.
- the polyoxyethylene hydrogenated castor oil is preferably PEG60 hydrogenated castor oil.
- (F) diglycerin in an amount of 0.2 to 4% by mass based on the total amount of the base.
- (G) dimethicone having a kinematic viscosity of 50 mm 2 / s or more at 25 ° C. is contained in an amount of 2 to 5% by mass based on the total amount of the base.
- the non-woven fabric preferably contains polyester fibers and cellulosic fibers.
- the sheet-shaped cosmetic of the present invention is (A) Hydrophobic-modified polyether urethane and (B) Salt-type whitening agent and Since the non-woven fabric is impregnated with a base containing the above, the salt-type whitening agent can be contained without reducing the viscosity of the base, and there is no dripping even when applied to the skin, after the sheet is peeled off. It has an excellent stickiness and can be made non-sticky after being peeled off even though the sheet has high adhesion to the skin.
- the sheet-shaped cosmetic of the present invention is at least, (A) Hydrophobic-modified polyether urethane and (B) Salt-type whitening agent and
- the non-woven fabric is impregnated with a base containing the above.
- each component of the base and the non-woven fabric impregnating the base will be described.
- each component may be simply referred to as a component (A), a component (B), or the like.
- HDI is hexamethylene diisocyanate
- POE is polyoxyethylene
- PEG is polyethylene glycol
- POP is polyoxypropylene
- PPG is polypropylene glycol
- DPG is dipropylene glycol
- BG is butylene glycol
- EO ethylene oxide
- PO is an abbreviation for propylene oxide.
- hydrophobic-modified polyether urethane is a hydrophobic-modified polyether urethane represented by the following formula (I).
- R 1 , R 2 and R 4 independently represent an alkylene group having 2 to 4 carbon atoms or a phenylethylene group, respectively. It is preferably an alkylene group having 2 to 4 carbon atoms.
- R 3 represents an alkylene group having 1 to 10 carbon atoms which may have a urethane bond.
- R 5 represents a linear, branched or secondary alkyl group having 8 to 36 carbon atoms, preferably 12 to 24 carbon atoms.
- m is a number of 2 or more. It is preferably 2.
- h is a number of 1 or more. It is preferably 1.
- k is a number from 1 to 500. The number is preferably 100 to 300.
- n is a number from 1 to 200. The number is preferably 10 to 100.
- the hydrophobically modified polyether urethane represented by the above formula (I) is, for example, R 1 -[(OR 2 ) k -OH] m (where R 1 , R 2 , k, m are defined above.
- a preferred example is a method obtained by reacting with an ether monoalcohol.
- R 1 to R 5 in the formula (I) are used R 1 ⁇ [(OR 2 ) k ⁇ OH] m , R 3 ⁇ (NCO) h + 1 , HO ⁇ (R 4 ⁇ O). ) Determined by n -R 5 .
- the polyether polyol compound represented by the above formula R 1 -[(OR 2 ) k -OH] m contains ethylene oxide, propylene oxide, butylene oxide, alkylene oxide such as epichlorohydrin, styrene oxide, etc. in the m-valent polyol. It can be done by addition polymerization.
- the polyol is preferably divalent to 8-valent, for example, dihydric alcohols such as ethylene glycol, propylene glycol, butylene glycol, hexamethylene glycol and neopentyl glycol; glycerin, trioxyisobutane, 1,2,3-.
- dihydric alcohols such as ethylene glycol, propylene glycol, butylene glycol, hexamethylene glycol and neopentyl glycol
- glycerin trioxyisobutane, 1,2,3-.
- R 2 is determined by the alkylene oxide, styrene oxide, etc. to be added, but it is particularly easy to obtain, and in order to exert an excellent effect, alkylene oxide or styrene oxide having 2 to 4 carbon atoms is used. preferable.
- the alkylene oxide, styrene oxide and the like to be added may be homopolymerized, two or more kinds of random polymerization or block polymerization.
- the method of addition may be a normal method.
- the degree of polymerization k is 1 to 500.
- the proportion of ethylene groups in R 2 is preferably 50 to 100% by mass of the total R 2 .
- the molecular weight of R 1 ⁇ [(OR 2 ) k ⁇ OH] m is preferably 500 to 100,000, and particularly preferably 1000 to 50,000.
- the polyisocyanate represented by the above formula R 3- (NCO) h + 1 is not particularly limited as long as it has two or more isocyanate groups in the molecule. Examples thereof include aliphatic diisocyanates, aromatic diisocyanates, alicyclic diisocyanates, biphenyl diisocyanates, di-, tri-, and tetraisocyanates of phenylmethane.
- aliphatic diisocyanis examples include methylene diisocyanate, dimethylene diisocyanate, trimethylene diisocyanate, tetramethylene diisocyanate, pentamethylene diisocyanate, hexamethylene diisocyanate, dipropyl ether diisocyanate, 2,2-dimethylpentane diisocyanate, 3-methoxyhexanediisocyanis, and the like.
- aromatic diisocyanate examples include metaphenylene diisocyanate, paraphenylene diisocyanate, 2,4-toluene diisocyanate, 2,6-toluene diisocyanate, dimethylbenzene diisocyanate, ethylbenzene diisocyanate, isopropylbenzene diisocyanate, and trizine diisocyanate, 1,4-.
- aromatic diisocyanate examples include metaphenylene diisocyanate, paraphenylene diisocyanate, 2,4-toluene diisocyanate, 2,6-toluene diisocyanate, dimethylbenzene diisocyanate, ethylbenzene diisocyanate, isopropylbenzene diisocyanate, and trizine diisocyanate, 1,4-.
- examples thereof include naphthalene diisocyanate, 1,5-naphthalene diisocyanate, 2,6-n
- Examples of the alicyclic diisocyanate include hydrogenated xylylene diisocyanate and isophorone diisocyanate.
- biphenyl diisocyanate examples include biphenyl diisocyanate, 3,3'-dimethylbiphenyl diisocyanate, 3,3'-dimethoxybiphenyl diisocyanate and the like.
- diisocyanate of phenylmethane examples include diphenylmethane-4,4'-diisocyanate, 2,2'-dimethyldiphenylmethane-4,4'-diisocyanate, diphenyldimethylmethane-4,4'-diisocyanate, 2,5,2'.
- phenylmethane triisocyanate examples include 1-methylbenzene-2,4,6-triisocyanate, 1,3,5-trimethylbenzene-2,4,6-triisocyanate and 1,3,7-naphthalentry.
- polyisocyanate compound may be used as a dimer or trimmer (isocyanurate bond) of these polyisocyanate compounds, or may be reacted with an amine and used as a biuret.
- a polyisocyanate having a urethane bond obtained by reacting these polyisocyanate compounds with a polyol can also be used.
- the polyol those having a valence of 2 to 8 are preferable, and the above-mentioned polyol is preferable.
- R 3- (NCO) h + 1 the polyisocyanate having this urethane bond is preferable.
- the polyether monoalcohol represented by the above formula HO- (R 4 -O) n -R 5 is not particularly limited as long as it is a linear and branched chain or a secondary monohydric alcohol polyether.
- Such compounds can be obtained by addition polymerization of ethylene oxide, propylene oxide, butylene oxide, alkylene oxide such as epichlorohydrin, styrene oxide and the like to linear and branched chain or secondary monohydric alcohols.
- the secondary alcohol is represented by the following formula (IV).
- R 5 is a group excluding the hydroxyl group in the above formulas (II) to (IV).
- R 6 , R 7 , R 8 , R 10 and R 11 are hydrocarbon groups or fluorocarbon groups, for example, an alkyl group, an alkenyl group, an alkylaryl group and a cycloalkyl group. , Cycloalkyl group, etc.
- alkyl group examples include methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tertiarybutyl, pentyl, isopentyl, neopentyl, tertiarypentyl, hexyl, heptyl, octyl, 2-ethylhexyl, nonyl, decyl, undecyl and dodecyl.
- Tridecyl Tridecyl, Isotridecyl, Myristyl, Palmytyl, Stearyl, Isostearyl, Icosyl, Docosyl, Tetracosyl, Triacontyl, 2-octyldodecyl, 2-Dodecylhexadecyl, 2-Tetradecyl octadecyl, monomethyl branched-isostearyl and the like.
- alkenyl group examples include vinyl, allyl, propenyl, isopropenyl, butenyl, pentenyl, isopentenyl, hexenyl, heptenyl, octenyl, nonenyl, decenyl, undecenyl, dodecenyl, tetradecenyl, oleyl and the like.
- alkylaryl group examples include phenyl, toluyl, xylyl, cumenyl, mesityl, benzyl, phenethyl, styryl, cinnamyl, benzhydryl, trityl, ethylphenyl, propylphenyl, butylphenyl, pentylphenyl, hexylphenyl, heptylphenyl, octylphenyl and nonyl. Examples thereof include phenyl, ⁇ -naphthyl, ⁇ -naphthyl group and the like.
- Examples of the cycloalkyl group and the cycloalkenyl group include cyclopentyl, cyclohexyl, cycloheptyl, methylcyclopentyl, methylcyclohexyl, methylcycloheptyl, cyclopentenyl, cyclohexenyl, cycloheptenyl, methylcyclopentenyl, methylcyclohexenyl and methylcycloheptenyl groups. And so on.
- R 9 is a hydrocarbon group or a fluorocarbon group, for example, an alkylene group, an alkenylene group, an alkylarylene group, a cycloalkylene group, a cycloalkenylene group and the like.
- R 5 is a hydrocarbon group or a fluorocarbon group, of which an alkyl group is preferable, and the total number of carbon atoms thereof is preferably 8 to 36, particularly preferably 12 to 24.
- the alkylene oxide, styrene oxide and the like to be added may be homopolymerized, two or more kinds of random polymerization or block polymerization.
- the method of addition may be a normal method.
- the degree of polymerization n is 0 to 1000, preferably 1 to 200, and more preferably 10 to 200.
- the ratio of the ethylene group to R 4 is preferably 50 to 100% by mass, more preferably 65 to 100% by mass of the total R 4 .
- the copolymer may be obtained by heating at 80 to 90 ° C. for 1 to 3 hours in the same manner as the reaction between ordinary polyether and isocyanate and reacting. Can be done.
- the polyether monoalcohol (c) represented by (R 4 -O) n-R 5 may be produced as a by-product.
- the main product is a c-b-a-bc-type copolymer represented by the formula (I), but in addition, c-bc-type and c-b are produced.
- -(A-b) x -ab-c type copolymers may be produced as by-products. In this case, it can be used in the present invention in the form of a mixture containing the copolymer of the formula (I) without separating the copolymer of the formula (I) in particular.
- a particularly preferable example is a hydrophobically modified polyether urethane having an INCI name of "(PEG-240 / decyltetradeceth-20 / HDI) copolymer (PEG-240 / HDI COPOLYMER BISDECYLTETRADECETH-20 ETHER)".
- the copolymer is commercially available from ADEKA Corporation under the trade name "ADEKANOR GT-700".
- the blending amount of the hydrophobically modified polyether urethane is preferably 0.1 to 3% by mass, more preferably 0.3 to 2.5% by mass, and further 0.5 to 3 with respect to the total amount of the base. It is preferably by mass%.
- the (B) salt-type whitening agent can be contained without further reducing the viscosity of the base, and it is unique and chewy even after the sheet is peeled off.
- the feel is more obtained and the content is 3% by mass or less, the sheet has better adhesion to the skin and can be made less sticky after being peeled off.
- Salt-type whitening agent means a water-soluble agent capable of forming a salt, and may be a whitening agent in a salt-formed state or reacts with other compounds. It may be a whitening agent capable of forming a salt. As long as it is a water-soluble drug, the desired drug can be blended without particular limitation. For example, salts of L-ascorbic acid and its derivatives, salts of tranexamic acid and its derivatives, salts of alkoxysalicylic acid and its derivatives, salts of glutathione and its derivatives, and the like are preferred.
- L-ascorbic acid is generally called vitamin C, and has a cellular respiration effect, an enzyme activating effect, a collagen forming effect, and a melanin reducing effect due to a strong reducing action.
- L-ascorbic acid derivative include L-ascorbic acid monoalkyl esters such as L-ascorbic acid monostearate, L-ascorbic acid monopalmitate, and L-ascorbic acid monoolate; L-ascorbic acid monophosphate ester, L-.
- L-ascorbic acid monoesters such as ascorbic acid-2-sulfate ester
- L-ascorbic acid dialkyl esters such as L-ascorbic acid distearate, L-ascorbic acid dipalmitate, L-ascorbic acid dioleate
- L-ascorbic acid tristeer L-ascorbic acid trialkyl esters such as rate, L-ascorbic acid tripalmitate, L-ascorbic acid triolate
- L-ascorbic acid triesters such as L-ascorbic acid triphosphate
- L-ascorbic acid 2- Examples thereof include L-ascorbic acid glucosides such as glucoside.
- the present invention is preferably used in the form of salts of L-ascorbic acid, L-ascorbic acid phosphate ester, L-ascorbic acid-2-sulfate ester, L-ascorbic acid 2-glucoside, and magnesium ascorbic acid phosphate. ..
- tranexamic acid derivative examples include a dimer of tranexamic acid (eg, trans-4- (trans-aminomethylcyclohexanecarbonyl) aminomethylcyclohexanecarboxylic acid, etc.), an ester of tranexamic acid and hydroquinone (eg, 4-).
- a dimer of tranexamic acid eg, trans-4- (trans-aminomethylcyclohexanecarbonyl) aminomethylcyclohexanecarboxylic acid, etc.
- an ester of tranexamic acid and hydroquinone eg, 4-
- tranexamic acid 4'-hydroxyphenyl ester, etc.
- ester of tranexamic acid and gentisic acid eg, 2- (trans-4-aminomethylcyclohexylcarbonyloxy) -5-hydroxybenzoic acid, etc.
- Amido form of tranexamic acid eg, trans-4-aminomethylcyclohexanecarboxylic acid methylamide, trans-4- (p-methoxybenzoyl) aminomethylcyclohexanecarboxylic acid, trans-4-guanidinomethylcyclohexanecarboxylic acid, etc.
- it is preferably used in the form of a salt of tranexamic acid or a salt of a tranexamic acid derivative.
- Alkoxysalicylic acid is obtained by substituting a hydrogen atom at any of the 3-position, 4-position or 5-position of salicylic acid with an alkoxy group, and the alkoxy group as a substituent is preferably a methoxy group, an ethoxy group or a propoxy group.
- compound names include 3-methoxysalicylic acid, 3-ethoxysalicylic acid, 4-methoxysalicylic acid, 4-ethoxysalicylic acid, 4-propoxysalicylic acid, 4-isopropoxysalicylic acid, 4-butoxysalicylic acid, and 5-methoxysalicylic acid. , 5-ethoxysalicylic acid, 5-propoxysalicylic acid and the like. In the present invention, it is preferably used in the form of each salt of alkoxysalicylic acid and its derivatives (esters, etc.).
- the salt of the above-mentioned drug is not particularly limited, and examples thereof include alkali metal salts such as sodium salt, potassium salt and calcium salt, alkaline earth metal salts, and salts such as ammonium salt and amino acid salt.
- alkali metal salts such as sodium salt, potassium salt and calcium salt
- alkaline earth metal salts such as calcium salt
- salts such as ammonium salt and amino acid salt.
- 4-methoxysalicylic acid potassium salt or ascorbic acid glucoside is preferably used.
- the (B) salt-type whitening agent one type or two or more types can be used, and the blending amount thereof is arbitrary, and it cannot be said unconditionally because it depends on the (B) salt-type whitening agent to be used, but it is a base. It is preferably 0.001 to 3% by mass, more preferably 0.05 to 2% by mass, based on the total amount. When it is 0.001% by mass or more, the whitening effect can be further realized, and when it is 3% by mass or less, the usability can be improved.
- the mass ratio of (A) hydrophobically modified polyether urethane to (B) salt-type whitening agent is preferably 0.2 to 1, and more preferably 0.3 to 0.8.
- the mass ratio of the (A) hydrophobically modified polyether urethane to the salt-type whitening agent is 0.3 or more, so that the (B) salt-type whitening agent is contained without further reducing the viscosity of the base.
- the sheet has a more chewy and unique feel even after the sheet is peeled off, and the mass ratio is 1 or less, so that the sheet has better adhesion to the skin and is less sticky after being peeled off. Can be done.
- the base of the present invention preferably contains (C) carboxyvinyl polymer.
- the carboxyvinyl polymer (carbomer) is a water-soluble vinyl polymer having a carboxyl group, and specifically, a polymer having acrylic acid and / or methacrylic acid as a main chain.
- Carbopol 940, Carbopol 941, Carbopol 980, Carbopol 981 can be used as a commercially available product of the carboxyvinyl polymer.
- the blending amount of the (C) carboxyvinyl polymer is preferably 0.01 to 1% by mass, more preferably 0.05 to 0.8% by mass, and further preferably 0.1 to 0.5% by mass.
- the static viscosity can be made more sufficient, so that creaming of the base can be prevented and stable can be maintained. Further, when it is 1% by mass or less, the adhesion of the sheet to the skin is better, and it can be made less sticky after peeling.
- the base of the present invention preferably contains (D) polyoxyethylene fatty acid glyceryl or polyoxyethylene hydrogenated castor oil.
- the polyoxyethylene fatty acid glyceryl or the polyoxyethylene hydrogenated castor oil may contain at least one of them, and may contain both of them.
- polyoxyethylene fatty acid glyceryl examples include (mono) PEG-8 glyceryl isostearate, (mono) PEG-20 glyceryl isostearate, (mono) PEG-60 glyceryl isostearate, PEG-20 glyceryl triisostearate, and coconut oil. Examples include the fatty acid PEG-7 glyceryl.
- the polyoxyethylene fatty acid glyceryl preferably has 5 to 20 moles of polyoxyethylene added.
- Emarex GWIS-108 manufactured by Nippon Emulsion Co., Ltd.
- Emarex GWIS which is PEG-20 glyceryl (mono) isostearate.
- Emarex GWIS-160 which is glyceryl monoisostearate of polyoxyethylene (60)
- Emarex GWIS-320 which is glyceryl of polyoxyethylene (20) triisostearate
- PEG- 7 Palm oil fatty acid glyceryl such as cethiol HE (manufactured by Cognis Japan Co., Ltd.) and glycerox HE (manufactured by CRODA).
- polyoxyethylene hydrogenated castor oil The polyoxyethylene hydrogenated castor oil is preferably hydrophilic, and the average number of moles of ethylene oxide added is preferably 30 to 100, more preferably 40 to 80.
- Commercially available products of polyoxyethylene cured castor oil include Nikkor HCO-30, which is PEG30 hydrogenated castor oil, Nikkor HCO-40, which is PEG40 hydrogenated castor oil, Nikkor HCO-60, which is PEG60 hydrogenated castor oil, and PEG100 water. Examples thereof include Nikkor HCO-100, which is a castor oil, (all manufactured by Nikko Chemicals Co., Ltd.). Of these, PEG60 hydrogenated castor oil can be particularly preferably used.
- the blending amount of the component (D) is preferably 0.01 to 1% by mass, more preferably 0.05 to 0.8% by mass, and further preferably 0.08 to 0.5% by mass.
- the blending amount of the component (D) is 0.01% by mass or more, the fluffy feel when the sheet is touched can be further maintained, and the emulsification stability can be further improved. Further, when it is 1% by mass or less, the adhesion of the sheet to the skin is better, and it can be made less sticky after peeling.
- the base of the present invention preferably contains (E) higher fatty acid.
- the higher fatty acid is a linear or branched higher fatty acid having a saturated or unsaturated hydrocarbon group and having 12 to 22 carbon atoms, and is liquid at room temperature (25 ° C.). Is preferable. Examples thereof include linear fatty acids such as oleic acid, linoleic acid and linolenic acid, and branched chain fatty acids such as isostearic acid and isostriatic acid. In particular, isostearic acid can be preferably used.
- the blending amount of the higher fatty acid is preferably 0.01 to 3% by mass, more preferably 0.05 to 2% by mass, further 0.1 to 1.5% by mass, and particularly 0.2 to 1% by mass. % Is desirable.
- D When the blending amount of the higher fatty acid is 0.01% by mass or more, the sheet can be made more adherent to the skin but not sticky. Further, when the content is 3% by mass or less, the skin cannot be made slimy after the sheet is peeled off.
- the mass ratio of (A) the isostearic acid to the hydrophobically modified polyether urethane is preferably 0.3 to 1.6.
- the mass ratio of isostearic acid to the hydrophobically modified polyether urethane is 0.3 or more, the sheet adheres better to the skin and can be made less sticky after being peeled off. Further, when it is 1.6 or less, it is possible to prevent the skin from becoming slimy after the sheet is peeled off.
- the base of the present invention contains (F) diglycerin, which is a polyhydric alcohol having three or more hydroxyl groups in one molecule, in an amount of 0.2 to 4% by mass based on the total amount of the base. good.
- diglycerin is a polyhydric alcohol having three or more hydroxyl groups in one molecule, in an amount of 0.2 to 4% by mass based on the total amount of the base. good.
- the amount of diglycerin is in the range of 0.2 to 4% by mass with respect to the total amount of the base, the adhesion of the sheet to the skin is better and the sheet can be made less sticky after being peeled off.
- the base of the present invention contains (G) dimethicone having a kinematic viscosity of 50 mm 2 / s or more at 25 ° C.
- the base of the present invention contains (G) dimethicone having a kinematic viscosity of 50 mm 2 / s or more at 25 ° C. in an amount of 2 to 5 mass with respect to the total amount of the base. May be included.
- the blending amount of the component (G) is in the range of 2 to 5% by mass with respect to the total amount of the base, the sheet has better adhesion to the skin and can be made less sticky after being peeled off.
- the sheet-shaped cosmetic of the present invention is obtained by impregnating a non-woven fabric with the above base.
- the non-woven fabric to be impregnated is not particularly limited, but may be a single layer or a laminate of single fibers or mixed fibers selected from natural fibers, regenerated fibers, and synthetic fibers.
- a single fiber selected from cellulose fibers (cotton, pulp, lyocell, cupra, rayon, acetate, etc.), acrylic fibers, polyester fibers, polyethylene, polyolefin fibers such as polypropylene, polyurethane fibers, polyamide fibers, etc.
- Mixed fibers are preferred.
- a mixed fiber of polyester fiber and cellulosic fiber is preferable, and a mixed fiber of cotton, pulp and polyethylene terephthalate is more preferable.
- the thickness of the sheet is not particularly limited and may be appropriately selected depending on the intended purpose.
- the sheet is preferably 0.1 to 10 mm, more preferably 0.1 to 5 mm.
- the basis weight is preferably 10 to 100 g / m 2 , more preferably 30 to 80 g / m 2 . If the basis weight is 10 g / m 2 or more, it will not be torn during use, and if it is 100 g / m 2 or less, high cost can be suppressed.
- the shape of the sheet is not particularly limited, and examples thereof include an ellipse, a circle, a heart shape, a semicircle, a semi-elliptical shape, a trapezoid, and a face shape in addition to a square and a rectangle.
- the method of impregnating the sheet with the base can be performed by a known means, and examples thereof include a dropping method, a spraying method, a pressurizing method, and a dipping processing method. Use one or more sheets as they are or by folding them, and impregnate them with the base.
- the impregnation amount of the base to be impregnated into the nonwoven fabric is not particularly limited, but is appropriately adjusted according to the characteristics of the nonwoven fabric and the base, and the impregnation amount is preferably 1.5 to 25 times the mass of the nonwoven fabric.
- the sheet impregnated with the base in a highly airtight container, and in particular, the package made of aluminum laminate or the package coated on the inner surface with polyethylene terephthalate (PET) does not allow light to pass through and is airtight. It is more preferable to load it in a bag or the like in a sealed manner.
- PET polyethylene terephthalate
- the base to be impregnated in the sheet-shaped cosmetic of the present invention includes components usually used for external skin preparations such as cosmetics and pharmaceuticals, for example, an aqueous component and an oily component. Powder and the like can be appropriately blended as needed.
- aqueous component examples include water and a water-soluble component.
- water-soluble component examples include lower alcohols, moisturizers, water-soluble polymers (natural, semi-synthetic, synthetic, inorganic) and the like.
- the water-soluble polymer refers to a substance that is not intended for thickening.
- lower alcohols examples include ethanol, propanol, butanol, pentanol, hexanol and the like.
- Moisturizing agents include glycerin, diethylene glycol, butylene glycol, polyethylene glycol, hexylene glycol, xylitol, sorbitol, martitol, chondroitin sulfate, hyaluronic acid, mucoitin sulfate, caronic acid, atelocollagen, elastin, amino acids, nucleic acids, cholesteryl-12-. Examples thereof include hydroxystearate, sodium lactate, bile acid salt, dl-pyrrolidone carboxylate, short chain soluble collagen, diglycerin (EO) PO adduct, isaiyobara extract, sardine extract, melilot extract and the like. To.
- Natural water-soluble polymers include ala-avia gum, tragacanto gum, galactan, guar gum, locust bean gum, tamarint gum, carob gum, karaya gum, carrageenan, pectin, canten, quince seed (malmero), algae colloid (cassow extract), starch (rice, corn).
- Potato, wheat plant-based water-soluble polymers such as glycyrrhizic acid; microbial-based water-soluble polymers such as xanthan gum, dextran, succinoglycan, and burran; animal-based water-soluble polymers such as collagen, casein, albumin, and gelatin. Etc. are exemplified.
- Examples of the semi-synthetic water-soluble polymer include starch-based water-soluble polymers such as carboxymethyl starch and methyl hydroxypropyl starch; methyl cellulose, nitrocellulose, ethyl cellulose, methyl hydroxypropyl cellulose, hydroxyethyl cellulose, cellulosic sodium sulfate, hydroxypropyl cellulose, and carboxy.
- Cellulose-based water-soluble polymers such as methyl cellulose (CMC), crystalline cellulose, and cellulose powder; arginic acid-based water-soluble polymers such as sodium alginate and propylene glycol alginate are exemplified.
- Examples of the synthetic water-soluble polymer include vinyl-based water-soluble polymers such as polyvinyl alcohol, polyvinyl methyl ether, and polyvinylpyrrolidone; and polyoxyethylene-based water-soluble polymers such as polyethylene glycol 20,000, 4,000,000, and 600,000. Sexual polymer; Copolymer-based water-soluble polymer such as polyoxyethylene polyoxypropylene copolymer; Acrylic-based water-soluble polymer such as sodium polyacrylate, polyethyl acrylate, and polyacrylamide, as well as polyethyleneimine and cationic polymer. Etc. are exemplified.
- inorganic water-soluble polymer examples include bentonite, AlMg silicate (bea gum), laponite, hectorite, and silicic acid anhydride.
- hydrophobic powder or hydrophilic powder can be used as the powder component. Further, not only the powder itself is hydrophobic or hydrophilic, but also the surface of the powder may be hydrophobized or hydrophilized.
- powder components include talc, kaolin, mica, silk mica (serisite), white mica, gold mica, synthetic mica, red mica, black mica, lithia mica, permiculite, magnesium carbonate, calcium carbonate, aluminum silicate, and kei.
- the method for hydrophobizing these powder components may be any method as long as it can impart water repellency, and the method is not limited, but for example, a vapor phase method, a liquid phase method, or an autoclave.
- a normal surface treatment method such as a method or a mechanochemical method can be used.
- the hydrophobic treatment agent is not particularly limited, but is not particularly limited, but is a fatty acid dextrin-treated powder, a trimethylsiloxysilicate-treated powder, a fluorine-modified trimethylsiloxysilicate-treated powder, a methylphenylsiloxysilicate-treated powder, and a fluorine-modified methylphenylsiloxysilicate-treated powder.
- Methyltricrolsilane Methyltrialkoxysilane, Hexamethyldisilane, dimethyldichlorosilane, dimethyldialkoxysilane, trimethylchlorsilane, Organic silyl compounds such as trimethylalkoxysilane, or powders treated with their fluorine-substituted powders, ethyltricrolsilane, ethyl.
- Organically modified silanes such as trialkoxysilanes, propyltrichlorosilanes, propyltrialkoxysilanes, hexyltrichlorosilanes, hexyltrialkoxysilanes, long-chain alkyltrichlorosilanes, long-chain alkyltriethoxysilanes, or powders treated with their fluorine substituents, amino.
- Examples thereof include modified polysiloxane-treated powder, fluorine-modified polysiloxane-treated powder, and fluorinated alkylphosphate-treated powder.
- the oily component to be blended in the base of the sheet-shaped cosmetic of the present invention is not particularly limited as long as it is an oily component that can be usually blended in cosmetics.
- examples include alcohol, synthetic ester oil, silicone oil and the like.
- Oils include avocado oil, camellia oil, evening primrose oil, turtle oil, macadamia nut oil, corn oil, mink oil, olive oil, rapeseed oil, egg yolk oil, sesame oil, persic oil, wheat germ oil, southern ka oil, castor oil, and flaxseed oil.
- Liquid fats and oils such as glycerin; cacao butter, palm oil, horse fat, hardened palm oil, palm oil, beef fat, sheep fat, hardened beef fat, palm kernel oil, pork fat, beef bone fat, mokuro kernel oil, hardened oil, beef leg Examples thereof include solid fats and oils such as fats, mokurou, and hardened castor oil.
- waxes examples include honey wax, candelilla wax, cotton wax, carnauba wax, bayberry wax, ibotarou, whale wax, monttan wax, nukarou, lanolin, capoc wax, lanolin acetate, liquid lanolin, sugar cane, lanolin fatty acid isopropyl, hexyl laurate, reduced lanolin, and jojo.
- examples thereof include barrow, hard lanolin, serrac wax, POE lanolin alcohol ether, POE lanolin alcohol acetate, POE cholesterol ether, lanolin fatty acid polyethylene glycol, POE hydrogenated lanolin alcohol ether and the like.
- hydrocarbon oil examples include liquid paraffin, zokerite, squalene, pristane, paraffin, selecin, squalene, petrolatum, and microcrystalline wax.
- Higher alcohols include linear alcohols such as lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, myristyl alcohol, oleyl alcohol, and cetostearyl alcohol; monostearyl glycerin ether (bacyl alcohol), 2-decyltetradecinol, and lanolin alcohol.
- linear alcohols such as lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, myristyl alcohol, oleyl alcohol, and cetostearyl alcohol
- monostearyl glycerin ether bacyl alcohol
- 2-decyltetradecinol 2-decyltetradecinol
- lanolin alcohol examples thereof include branched chain alcohols such as cholesterol, phytosterol, hexyldodecanol, isostearyl alcohol, and octyldodecanol.
- Synthetic ester oils include isopropyl myristate, cetyl octanate, octyldodecyl myristate, isopropyl palmitate, butyl stearate, hexyl laurate, myristyl myristate, decyl oleate, hexyldecyl dimethyloctanoate, cetyl lactate, myristyl lactate.
- silicone oil examples include chain polysiloxanes other than (F) such as dimethylpolysiloxane, methylphenylpolysiloxane, and methylhydrogenpolysiloxane; decamethylpolysiloxane, dodecamethylpolysiloxane, tetramethyltetrahydrogenpolysiloxane, and the like. Cyclic polysiloxane; silicone resin, silicone rubber, etc. forming a three-dimensional network structure are exemplified.
- the emulsifier examples include glycerin or polyglycerin fatty acid esters, propylene glycol fatty acid esters, POE sorbitan fatty acid esters, POE sorbit fatty acid esters, POE fatty acid esters, POE alkyl ethers, POE alkyl phenyl ethers, and POE / POP alkyl.
- ethers One or more selected from ethers, POE beeswax / lanolin derivatives, alkanolamides, POEpropylene glycol fatty acid esters, POE alkylamines, and POE fatty acid amides are blended.
- Examples of other compoundable components other than the above-exemplified components include preservatives (ethylparaben, butylparaben, etc.); anti-inflammatory agents (eg, glycyrrhizinic acid derivative, glycyrrhetinic acid derivative, salicylic acid derivative, hinokithiol, zinc oxide, allantin, etc.). ); Whitening agents other than (B) (eg, Yukinoshita extract, Arbutin, etc.); Various extracts (eg, Oubaku, Ouren, Shikon, Shakuyaku, Senburi, Birch, Sage, Biwa, Carrot, Aloe, Zeniaoi, Iris, etc.
- preservatives ethylparaben, butylparaben, etc.
- anti-inflammatory agents eg, glycyrrhizinic acid derivative, glycyrrhetinic acid derivative, salicylic acid derivative, hinokithi
- Activators eg, Royal Jelly, Photosensitizer, Cholesterol Derivatives, etc.
- Trazoline Trazoline, acetylcholine, verapamil, cepharanthin, ⁇ -orizanol, etc.
- Antioxidants tocopherol acetate, etc.
- Antifat leak agents eg, sulfur, thiantol, etc.
- Anti-inflammatory agents eg, tranexamic acid, thiotaurine, hypotaurine, etc.
- Examples include an ultraviolet absorber. However, it is not limited to these examples.
- Bases were prepared according to the formulations shown in Tables 1 to 3 below, and the static viscosity and kinematic viscosity of the prepared bases were measured under the following conditions.
- the base is impregnated into a non-woven fabric (mixed fiber made of cotton, pulp, polyethylene terephthalate, basis weight 70 g / m 2 , impregnation amount 14.5 times) to prepare a sheet-shaped cosmetic, and the usability is based on the following criteria. evaluated.
- the prepared base was measured for viscosity at a shear rate of 0.05 [1 / s] in an atmosphere of 25 ° C. using MCR300 (manufactured by Antonio-Paar) as a leometer.
- Examples 1 and 2 shown in Table 1 did not drip even when applied to the skin, had good adhesion to the sheet, and had an excellent stickiness after the sheet was peeled off.
- (A) the sheet-shaped cosmetics of Comparative Examples 1 and 2 containing no hydrophobically modified polyether urethane have remarkable dripping when applied to the skin, and also have adhesiveness and a sticky feeling after the sheet is peeled off. I could't get it.
- Examples 3 and 4 contain ascorbic acid glucoside as a salt-type whitening agent, but as in Examples 1 and 2, there is no dripping even when applied to the skin, the sheet adheres well, and the sheet is used. It had an excellent feeling of stickiness after being peeled off.
- Examples 5 to 8 shown in Table 2 are examples in which isostearic acid is further added in the formulation of Example 1, and Examples 9 and 10 are examples in which the amount of (A) hydrophobically modified polyether urethane is reduced.
- Example 11 shown in Table 3 is an example in which the amount of the activator is reduced
- Examples 12 and 13 are examples in which polyoxyethylene hydrogenated castor oil is added
- Example 14 is an example in which dimethicone having a kinematic viscosity of 50 mm 2 / s or more is added
- Example 15 is an example in which diglycerin is added
- Example 16 is an example in which dipropylene glycol is added.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
[Problem] In this sheet-like cosmetic, a salt‐type whitening agent can be incorporated without reducing the viscosity of a base, liquid-dropping is not caused even when pasted on the skin, a springy feeling after peeling off the sheet is excellent, and there is no stickiness after peeling off the sheet in spite of high adhesiveness of the sheet to the skin. [Solution] This sheet-like cosmetic is obtained by impregnating a nonwoven fabric with a base, which contains at least (A) hydrophobically modified polyether urethane and (B) a salt‐type whitening agent.
Description
本発明は、基剤を含浸したシート状化粧料に関するものである。
The present invention relates to a sheet-like cosmetic product impregnated with a base.
美白剤を配合した皮膚化粧料は広く知られており、例えば特許文献1には、トラネキサム酸やアスコルビン酸グルコシドを配合した皮膚化粧料が記載されている。また特許文献2には、L-アスコルビン酸2-グルコシド、3-O-エチルアスコルビン酸、コウジ酸、エラグ酸、ハイドロキノンβ-D-グルコシド、4-n-ブチルレゾルシノール、5,5’-ジプロピルビフェニル-2,2’-ジオール、トラネキサム酸セチル塩酸塩、trans-4-(アミノメチル)シクロヘキサンカルボン酸、ニコチン酸アミド、および4-メトキシサリチル酸カリウム塩を配合したゲル状組成物が記載されている。
Skin cosmetics containing a whitening agent are widely known. For example, Patent Document 1 describes skin cosmetics containing tranexamic acid or ascorbic acid glucoside. Further, Patent Document 2 describes L-ascorbic acid 2-glucoside, 3-O-ethylascorbic acid, kodiic acid, ellagic acid, hydroquinone β-D-glucoside, 4-n-butylresorcinol, 5,5'-dipropyl. Described is a gel composition comprising biphenyl-2,2'-diol, cetyl tranexamic acid hydrochloride, trans-4- (aminomethyl) cyclohexanecarboxylic acid, nicotinic acid amide, and potassium 4-methoxysalicylic acid salt. ..
一方、化粧料を不織布に含浸させたマスク等のシート状化粧料が知られている。例えば、特許文献3には、有効成分として、トラネキサム酸や4-メトキシサリチル酸カリウム塩等の美白成分、抗炎症成分および保湿成分を含有し、アルカリゲネス産生多糖体を含有するシート状化粧料が記載されている。
On the other hand, sheet-shaped cosmetics such as masks in which a non-woven fabric is impregnated with cosmetics are known. For example, Patent Document 3 describes a sheet-shaped cosmetic containing as an active ingredient a whitening ingredient such as tranexamic acid or 4-methoxysalicylic acid potassium salt, an anti-inflammatory ingredient and a moisturizing ingredient, and containing an alkaligenes-producing polysaccharide. ing.
上記のような化粧料を不織布に含浸させたシート状化粧料は、肌に載せた時の液だれを抑制するために含侵させている基剤は高粘度にしたいという要求がある。しかし、4-メトキシサリチル酸塩等のいわゆる塩型美白薬剤は、その塩が化粧品に汎用的に用いられる増粘剤の粘度を低減させてしまうため、塩型美白薬剤を含有しながら、液だれがなく肌への密着性が高いシート状化粧料はこれまでなかった。
For sheet-like cosmetics impregnated with the above-mentioned cosmetics in a non-woven fabric, there is a demand for the base impregnated to have a high viscosity in order to suppress dripping when placed on the skin. However, so-called salt-type whitening agents such as 4-methoxysalicylate reduce the viscosity of thickeners commonly used in cosmetics, so that dripping occurs while containing the salt-type whitening agent. There has never been a sheet-like cosmetic that has high adhesion to the skin.
本発明は上記課題に鑑みなされたものであり、基剤の粘度を低減させることなく塩型美白薬剤を含有させることができ、肌に貼付しても液だれがなく、シートを剥がした後のもちもち感に優れ、肌に対するシートの密着性が高いにもかかわらず剥がした後にべたつきのないシート状化粧料を提供することを目的とするものである。
The present invention has been made in view of the above problems, and can contain a salt-type whitening agent without reducing the viscosity of the base, does not drip even when applied to the skin, and after peeling off the sheet. The purpose of the present invention is to provide a sheet-like cosmetic that has excellent stickiness and is not sticky after being peeled off even though the sheet has high adhesion to the skin.
本発明のシート状化粧料は、
少なくとも、
(A)疎水変性ポリエーテルウレタンと、
(B)塩型美白薬剤と、
を含む基剤を、不織布に含浸させてなるものである。 The sheet-shaped cosmetic of the present invention is
at least,
(A) Hydrophobic-modified polyether urethane and
(B) Salt-type whitening agent and
The non-woven fabric is impregnated with a base containing the above.
少なくとも、
(A)疎水変性ポリエーテルウレタンと、
(B)塩型美白薬剤と、
を含む基剤を、不織布に含浸させてなるものである。 The sheet-shaped cosmetic of the present invention is
at least,
(A) Hydrophobic-modified polyether urethane and
(B) Salt-type whitening agent and
The non-woven fabric is impregnated with a base containing the above.
(B)塩型美白薬剤は4-メトキシサリチル酸カリウム塩またはアスコルビン酸グルコシドであることが好ましい。
(B) The salt-type whitening agent is preferably 4-methoxysalicylic acid potassium salt or ascorbic acid glucoside.
(B)塩型美白薬剤に対する(A)疎水変性ポリエーテルウレタンの質量比は0.2~1であることが好ましい。
The mass ratio of (A) hydrophobically modified polyether urethane to (B) salt-type whitening agent is preferably 0.2 to 1.
さらに(C)カルボキシビニルポリマーを含むことが好ましい。
It is preferable to further contain (C) carboxyvinyl polymer.
さらに(D)ポリオキシエチレン脂肪酸グリセリルまたはポリオキシエチレン硬化ヒマシ油の少なくともいずれかを含むことが好ましい。
Further, it is preferable to contain at least one of (D) polyoxyethylene fatty acid glyceryl or polyoxyethylene hydrogenated castor oil.
さらに(E)イソステアリン酸を含むことが好ましい。
It is preferable to further contain (E) isostearic acid.
(A)疎水変性ポリエーテルウレタンは(PEG-240/デシルテトラデセス-20/HDI)コポリマーであることが好ましい。
(A) The hydrophobically modified polyether urethane is preferably a (PEG-240 / decyltetradeceth-20 / HDI) copolymer.
(D)ポリオキシエチレン脂肪酸グリセリルは(モノ)イソステアリン酸PEG-20グリセリルであることが好ましい。
The (D) polyoxyethylene fatty acid glyceryl is preferably PEG-20 glyceryl (mono) isostearate.
(D)ポリオキシエチレン硬化ヒマシ油はPEG60水添ヒマシ油であることが好ましい。
(D) The polyoxyethylene hydrogenated castor oil is preferably PEG60 hydrogenated castor oil.
さらに(F)ジグリセリンを基剤全量に対し0.2~4質量%含むことが好ましい。
Further, it is preferable to contain (F) diglycerin in an amount of 0.2 to 4% by mass based on the total amount of the base.
さらに(G)25℃における動粘度が50mm2/s以上のジメチコンを基剤全量に対し2~5質量%含むことが好ましい。
Further, it is preferable that (G) dimethicone having a kinematic viscosity of 50 mm 2 / s or more at 25 ° C. is contained in an amount of 2 to 5% by mass based on the total amount of the base.
不織布は、ポリエステル系繊維およびセルロース系繊維を含むものであることが好ましい。
The non-woven fabric preferably contains polyester fibers and cellulosic fibers.
本発明のシート状化粧料は、
(A)疎水変性ポリエーテルウレタンと、
(B)塩型美白薬剤と、
を含む基剤を不織布に含浸させてなるので、基剤の粘度を低減させることなく塩型美白薬剤を含有させることができ、肌に貼付しても液だれがなく、シートを剥がした後のもちもち感に優れ、肌に対するシートの密着性が高いにもかかわらず剥がした後にべたつきのないものとすることができる。 The sheet-shaped cosmetic of the present invention is
(A) Hydrophobic-modified polyether urethane and
(B) Salt-type whitening agent and
Since the non-woven fabric is impregnated with a base containing the above, the salt-type whitening agent can be contained without reducing the viscosity of the base, and there is no dripping even when applied to the skin, after the sheet is peeled off. It has an excellent stickiness and can be made non-sticky after being peeled off even though the sheet has high adhesion to the skin.
(A)疎水変性ポリエーテルウレタンと、
(B)塩型美白薬剤と、
を含む基剤を不織布に含浸させてなるので、基剤の粘度を低減させることなく塩型美白薬剤を含有させることができ、肌に貼付しても液だれがなく、シートを剥がした後のもちもち感に優れ、肌に対するシートの密着性が高いにもかかわらず剥がした後にべたつきのないものとすることができる。 The sheet-shaped cosmetic of the present invention is
(A) Hydrophobic-modified polyether urethane and
(B) Salt-type whitening agent and
Since the non-woven fabric is impregnated with a base containing the above, the salt-type whitening agent can be contained without reducing the viscosity of the base, and there is no dripping even when applied to the skin, after the sheet is peeled off. It has an excellent stickiness and can be made non-sticky after being peeled off even though the sheet has high adhesion to the skin.
以下、本発明のシート状化粧料について詳細に説明する。
本発明のシート状化粧料は、
少なくとも、
(A)疎水変性ポリエーテルウレタンと、
(B)塩型美白薬剤と、
を含む基剤を、不織布に含浸させてなるものである。
以下、基剤の各成分および基剤を含侵させる不織布について説明する。なお、以下において各成分を、単に(A)成分、(B)成分等と称する場合がある。
また、本明細書において、HDIはヘキサメチレンジイソシアネート、POEはポリオキシエチレン、PEGはポリエチレングリコール、POPはポリオキシプロピレン、PPGはポリプロピレングリコール、DPGはジプロピレングリコール、BGはブチレングリコール、EOはエチレンオキシド、POはプロピレンオキシドの略である。 Hereinafter, the sheet-shaped cosmetic of the present invention will be described in detail.
The sheet-shaped cosmetic of the present invention is
at least,
(A) Hydrophobic-modified polyether urethane and
(B) Salt-type whitening agent and
The non-woven fabric is impregnated with a base containing the above.
Hereinafter, each component of the base and the non-woven fabric impregnating the base will be described. In the following, each component may be simply referred to as a component (A), a component (B), or the like.
Further, in the present specification, HDI is hexamethylene diisocyanate, POE is polyoxyethylene, PEG is polyethylene glycol, POP is polyoxypropylene, PPG is polypropylene glycol, DPG is dipropylene glycol, BG is butylene glycol, and EO is ethylene oxide. PO is an abbreviation for propylene oxide.
本発明のシート状化粧料は、
少なくとも、
(A)疎水変性ポリエーテルウレタンと、
(B)塩型美白薬剤と、
を含む基剤を、不織布に含浸させてなるものである。
以下、基剤の各成分および基剤を含侵させる不織布について説明する。なお、以下において各成分を、単に(A)成分、(B)成分等と称する場合がある。
また、本明細書において、HDIはヘキサメチレンジイソシアネート、POEはポリオキシエチレン、PEGはポリエチレングリコール、POPはポリオキシプロピレン、PPGはポリプロピレングリコール、DPGはジプロピレングリコール、BGはブチレングリコール、EOはエチレンオキシド、POはプロピレンオキシドの略である。 Hereinafter, the sheet-shaped cosmetic of the present invention will be described in detail.
The sheet-shaped cosmetic of the present invention is
at least,
(A) Hydrophobic-modified polyether urethane and
(B) Salt-type whitening agent and
The non-woven fabric is impregnated with a base containing the above.
Hereinafter, each component of the base and the non-woven fabric impregnating the base will be described. In the following, each component may be simply referred to as a component (A), a component (B), or the like.
Further, in the present specification, HDI is hexamethylene diisocyanate, POE is polyoxyethylene, PEG is polyethylene glycol, POP is polyoxypropylene, PPG is polypropylene glycol, DPG is dipropylene glycol, BG is butylene glycol, and EO is ethylene oxide. PO is an abbreviation for propylene oxide.
(A)疎水変性ポリエーテルウレタン
(A)疎水変性ポリエーテルウレタンは下記式(I)で表される疎水変性ポリエーテルウレタンである。 (A) Hydrophobic-modified polyether urethane (A) The hydrophobic-modified polyether urethane is a hydrophobic-modified polyether urethane represented by the following formula (I).
(A)疎水変性ポリエーテルウレタンは下記式(I)で表される疎水変性ポリエーテルウレタンである。 (A) Hydrophobic-modified polyether urethane (A) The hydrophobic-modified polyether urethane is a hydrophobic-modified polyether urethane represented by the following formula (I).
上記式(I)中、R1、R2およびR4は、それぞれ独立に炭素原子数2~4のアルキレン基、またはフェニルエチレン基を示す。好ましくは炭素原子数2~4のアルキレン基である。
R3はウレタン結合を有していてもよい炭素原子数1~10のアルキレン基を示す。
R5は炭素原子数8~36、好ましくは12~24の、直鎖、分岐または2級のアルキル基を示す。
mは2以上の数である。好ましくは2である。
hは1以上の数である。好ましくは1である。
kは1~500の数である。好ましくは100~300の数である。
nは1~200の数である。好ましくは10~100の数である。 In the above formula (I), R 1 , R 2 and R 4 independently represent an alkylene group having 2 to 4 carbon atoms or a phenylethylene group, respectively. It is preferably an alkylene group having 2 to 4 carbon atoms.
R 3 represents an alkylene group having 1 to 10 carbon atoms which may have a urethane bond.
R 5 represents a linear, branched or secondary alkyl group having 8 to 36 carbon atoms, preferably 12 to 24 carbon atoms.
m is a number of 2 or more. It is preferably 2.
h is a number of 1 or more. It is preferably 1.
k is a number from 1 to 500. The number is preferably 100 to 300.
n is a number from 1 to 200. The number is preferably 10 to 100.
R3はウレタン結合を有していてもよい炭素原子数1~10のアルキレン基を示す。
R5は炭素原子数8~36、好ましくは12~24の、直鎖、分岐または2級のアルキル基を示す。
mは2以上の数である。好ましくは2である。
hは1以上の数である。好ましくは1である。
kは1~500の数である。好ましくは100~300の数である。
nは1~200の数である。好ましくは10~100の数である。 In the above formula (I), R 1 , R 2 and R 4 independently represent an alkylene group having 2 to 4 carbon atoms or a phenylethylene group, respectively. It is preferably an alkylene group having 2 to 4 carbon atoms.
R 3 represents an alkylene group having 1 to 10 carbon atoms which may have a urethane bond.
R 5 represents a linear, branched or secondary alkyl group having 8 to 36 carbon atoms, preferably 12 to 24 carbon atoms.
m is a number of 2 or more. It is preferably 2.
h is a number of 1 or more. It is preferably 1.
k is a number from 1 to 500. The number is preferably 100 to 300.
n is a number from 1 to 200. The number is preferably 10 to 100.
上記式(I)で表される疎水変性ポリエーテルウレタンは、例えば、R1-[(O-R2)k-OH]m(ここで、R1、R2、k、mは上記で定義したとおり)で表される1種または2種以上のポリエーテルポリオールと、R3-(NCO)h+1(ここで、R3、hは上記で定義したとおり)で表される1種または2種以上のポリイソシアネートと、HO-(R4-O)n-R5(ここで、R4、R5、nは上記で定義したとおり)で表される1種または2種以上のポリエーテルモノアルコールとを反応させることにより得る方法が好適例として挙げられる。
The hydrophobically modified polyether urethane represented by the above formula (I) is, for example, R 1 -[(OR 2 ) k -OH] m (where R 1 , R 2 , k, m are defined above. One or more of the polyether polyols represented by (as defined above) and one or more represented by R 3- (NCO) h + 1 (where R 3 , h are as defined above). Two or more polyisocyanates and one or more polys represented by HO- ( R4 -O) n - R5 ( where R4 , R5, n are as defined above). A preferred example is a method obtained by reacting with an ether monoalcohol.
この場合、式(I)中のR1~R5は、用いるR1-[(O-R2)k-OH]m、R3-(NCO)h+1、HO-(R4-O)n-R5により決定される。上記3者の仕込み比は、特に限定されるものでないが、ポリエーテルポリオールおよびポリエーテルモノアルコール由来の水酸基と、ポリイソシアネート由来のイソシアネート基の比が、NCO/OH=0.8:1~1.4:1であるのが好ましい。
In this case, R 1 to R 5 in the formula (I) are used R 1 − [(OR 2 ) k − OH] m , R 3 − (NCO) h + 1 , HO − (R 4 − O). ) Determined by n -R 5 . The charging ratio of the above three is not particularly limited, but the ratio of the hydroxyl group derived from the polyether polyol and the polyether monoalcohol to the isocyanate group derived from the polyisocyanate is NCO / OH = 0.8: 1 to 1. It is preferably 4: 1.
上記式R1-[(O-R2)k-OH]mで表されるポリエーテルポリオール化合物は、m価のポリオールにエチレンオキシド、プロピレンオキシド、ブチレンオキシド、エピクロルヒドリン等のアルキレンオキシド、スチレンオキシド等を付加重合することによりできる。
The polyether polyol compound represented by the above formula R 1 -[(OR 2 ) k -OH] m contains ethylene oxide, propylene oxide, butylene oxide, alkylene oxide such as epichlorohydrin, styrene oxide, etc. in the m-valent polyol. It can be done by addition polymerization.
ここでポリオールとしては、2~8価のものが好ましく、例えばエチレングリコール、プロピレングリコール、ブチレングリコール、ヘキサメチレングリコール、ネオペンチルグリコール等の2価アルコール;グリセリン、トリオキシイソブタン、1,2,3-ブタントリオール、1,2,3-ペンタトリオール、2-メチル-1,2,3-プロパントリオール、2-メチル-2,3,4-ブタントリオール、2-エチル-1,2,3-ブタントリオール、2,3,4-ペンタントリオール、2,3,4-ヘキサントリオール、4-プロピル-3,4,5-ヘプタントリオール、2,4-ジメチル-2,3,4-ペンタントリオール、ペンタメチルグリセリン、ペンタグリセリン、1,2,4-ブタントリオール、1,2,4-ペンタントリオール、トリメチロールエタン、トリメチロールプロパン等の3価アルコール;ペンタエリスリトール、1,2,3,4-ペンタンテトロール、2,3,4,5-ヘキサンテトロール、1,2,4,5-ペンタンテトロール、1,3,4,5-ヘキサンテトロール等の4価のアルコール;アドニット、アラビット、キシリット等の5価アルコール;ジペンタエリスリトール、ソルビット、マンニット、イジット等の6価アルコール;ショ糖等の8価アルコール等が挙げられる。
Here, the polyol is preferably divalent to 8-valent, for example, dihydric alcohols such as ethylene glycol, propylene glycol, butylene glycol, hexamethylene glycol and neopentyl glycol; glycerin, trioxyisobutane, 1,2,3-. Butantriol, 1,2,3-pentatriol, 2-methyl-1,2,3-propanetriol, 2-methyl-2,3,4-butanetriol, 2-ethyl-1,2,3-butanetriol , 2,3,4-pentantriol, 2,3,4-hexanetriol, 4-propyl-3,4,5-heptanetriol, 2,4-dimethyl-2,3,4-pentantriol, pentamethylglycerin , Pentaglycerin, 1,2,4-butanetriol, 1,2,4-pentantriol, trimethylolethane, trimethylolpropane and other trivalent alcohols; pentaerythritol, 1,2,3,4-pentantetrol, Tetravalent alcohols such as 2,3,4,5-hexanetetrol, 1,2,4,5-pentanetetrol, 1,3,4,5-hexanetetrol; 5 such as adnit, arabit, xylit, etc. Hyvalent alcohols; hexavalent alcohols such as dipentaerythritol, sorbit, mannit, and igit; octavalent alcohols such as sucrose and the like can be mentioned.
また、付加させるアルキレンオキシド、スチレンオキシド等により、R2が決定されるが、特に入手が容易であり、優れた効果を発揮させるためには、炭素原子数2~4のアルキレンオキシドあるいはスチレンオキシドが好ましい。
Further, R 2 is determined by the alkylene oxide, styrene oxide, etc. to be added, but it is particularly easy to obtain, and in order to exert an excellent effect, alkylene oxide or styrene oxide having 2 to 4 carbon atoms is used. preferable.
付加させるアルキレンオキシド、スチレンオキシド等は単独重合、2種類以上のランダム重合あるいはブロック重合であってよい。付加の方法は通常の方法であってよい。重合度kは1~500である。R2に占めるエチレン基の割合は、好ましくは全R2の50~100質量%である。
The alkylene oxide, styrene oxide and the like to be added may be homopolymerized, two or more kinds of random polymerization or block polymerization. The method of addition may be a normal method. The degree of polymerization k is 1 to 500. The proportion of ethylene groups in R 2 is preferably 50 to 100% by mass of the total R 2 .
R1-[(O-R2)k-OH]mの分子量は500~10万のものが好ましく、1000~5万のものが特に好ましい。
The molecular weight of R 1 − [(OR 2 ) k − OH] m is preferably 500 to 100,000, and particularly preferably 1000 to 50,000.
上記式R3-(NCO)h+1で表されるポリイソシアネートは、分子中に2個以上のイソシアネート基を有するものであれば特に限定されない。例えば、脂肪族ジイソシアネート、芳香族ジイソシアネート、脂環族ジイソシアネート、ビフェニルジイソシアネート、フェニルメタンのジ-、トリ-、テトライソシアネート等が挙げられる。
The polyisocyanate represented by the above formula R 3- (NCO) h + 1 is not particularly limited as long as it has two or more isocyanate groups in the molecule. Examples thereof include aliphatic diisocyanates, aromatic diisocyanates, alicyclic diisocyanates, biphenyl diisocyanates, di-, tri-, and tetraisocyanates of phenylmethane.
脂肪族ジイソシアネートとしては、例えば、メチレンジイソシアネート、ジメチレンジイソシアネート、トリメチレンジイソシアネート、テトラメチレンジイソシアネート、ペンタメチレンジイソシアネート、ヘキサメチレンジイソシアネート、ジプロピルエーテルジイソシアネート、2,2-ジメチルペンタンジイソシアネート、3-メトキシヘキサンジイソシアネート、オクタメチレンジイソシアネート、2,2,4-トリメチルペンタンジイソシアネート、ノナメチレンジイソシアネート、デカメチレンジイソシアネート、3-ブトキシヘキサンジイソシアネート、1,4-ブチレングリコールジプロピルエーテルジイソシアネート、チオジヘキシルジイソシアネート、メタキシリレンジイソシアネート、パラキシリレンジイソシアネート、テトラメチルキシリレンジイソシアネート等が挙げられる。
Examples of the aliphatic diisocyanis include methylene diisocyanate, dimethylene diisocyanate, trimethylene diisocyanate, tetramethylene diisocyanate, pentamethylene diisocyanate, hexamethylene diisocyanate, dipropyl ether diisocyanate, 2,2-dimethylpentane diisocyanate, 3-methoxyhexanediisocyanis, and the like. Hexamethylene diisocyanate, 2,2,4-trimethylpentane diisocyanate, nonamethylene diisocyanate, decamethylene diisocyanate, 3-butoxyhexane diisocyanate, 1,4-butylene glycol dipropyl ether diisocyanate, thiodihexyl diisocyanate, metaxylylene diisocyanate, paraximyl Examples thereof include range isocyanate and tetramethylxylylene diisocyanate.
芳香族ジイソシアネートとしては、例えば、メタフェニレンジイソシアネート、パラフェニレンジイソシアネート、2,4-トリレンジイソシアネート、2,6-トリレンジイソシアネート、ジメチルベンゼンジイソシアネート、エチルベンゼンジイソシアネート、イソプロピルベンゼンジイソシアネート、トリジンジイソシアネート、1,4-ナフタレンジイソシアネート、1,5-ナフタレンジイソシアネート、2,6-ナフタレンジイソシアネート、2,7-ナフタレンジイソシアネート等が挙げられる。
Examples of the aromatic diisocyanate include metaphenylene diisocyanate, paraphenylene diisocyanate, 2,4-toluene diisocyanate, 2,6-toluene diisocyanate, dimethylbenzene diisocyanate, ethylbenzene diisocyanate, isopropylbenzene diisocyanate, and trizine diisocyanate, 1,4-. Examples thereof include naphthalene diisocyanate, 1,5-naphthalene diisocyanate, 2,6-naphthalene diisocyanate, and 2,7-naphthalene diisocyanate.
脂環族ジイソシアネートとしては、例えば、水添キシリレンジイソシアネート、イソホロンジイソシアネート等が挙げられる。
Examples of the alicyclic diisocyanate include hydrogenated xylylene diisocyanate and isophorone diisocyanate.
ビフェニルジイソシアネートとしては、例えば、ビフェニルジイソシアネート、3,3’-ジメチルビフェニルジイソシアネート、3,3’-ジメトキシビフェニルジイソシアネート等が挙げられる。
Examples of the biphenyl diisocyanate include biphenyl diisocyanate, 3,3'-dimethylbiphenyl diisocyanate, 3,3'-dimethoxybiphenyl diisocyanate and the like.
フェニルメタンのジイソシアネートとしては、例えば、ジフェニルメタン-4,4’-ジイソシアネート、2,2’-ジメチルジフェニルメタン-4,4’-ジイソシアネート、ジフェニルジメチルメタン-4,4’-ジイソシアネート、2,5,2’,5’-テトラメチルジフェニルメタン-4,4’-ジイソシアネート、シクロヘキシルビス(4-イソシオントフェニル)メタン、3,3’-ジメトキシジフェニルメタン-4,4’-ジイソシアネート、4,4’-ジメトキシジフェニルメタン-3,3’-ジイソシアネート、4,4’-ジエトキシジフェニルメタン-3,3’-ジイソシアネート、2,2’-ジメチル-5,5’-ジメトキシジフェニルメタン-4,4’-ジイソシアネート、3,3’-ジクロロジフェニルジメチルメタン-4,4’-ジイソシアネート、ベンゾフェノン-3,3’-ジイソシアネート等が挙げられる。
Examples of the diisocyanate of phenylmethane include diphenylmethane-4,4'-diisocyanate, 2,2'-dimethyldiphenylmethane-4,4'-diisocyanate, diphenyldimethylmethane-4,4'-diisocyanate, 2,5,2'. , 5'-Tetramethyldiphenylmethane-4,4'-diisocyanate, cyclohexylbis (4-isosiontophenyl) methane, 3,3'-dimethoxydiphenylmethane-4,4'-diisocyanate, 4,4'-dimethoxydiphenylmethane- 3,3'-diisocyanate, 4,4'-diethoxydiphenylmethane-3,3'-diisocyanate, 2,2'-dimethyl-5,5'-dimethoxydiphenylmethane-4,4'-diisocyanate, 3,3'- Examples thereof include dichlorodiphenyldimethylmethane-4,4'-diisocyanate and benzophenone-3,3'-diisocyanate.
フェニルメタンのトリイソシアネートとしては、例えば、1-メチルベンゼン-2,4,6-トリイソシアネート、1,3,5-トリメチルベンゼン-2,4,6-トリイソシアネート、1,3,7-ナフタレントリイソシアネート、ビフェニル-2,4,4’-トリイソシアネート、ジフェニルメタン-2,4,4’-トリイソシアネート、3-メチルジフェニルメタン-4,6,4’-トリイソシアネート、トリフェニルメタン-4,4’,4’’-トリイソシアネート、1,6,11-ウンデカントリイソシアネート、1,8-ジイソシアネート-4-イソシアネートメチルオクタン、1,3,6-ヘキサメチレントリイソシアネート、ビシクロヘプタントリイソシアネート、トリス(イソシアネートフェニル)チオホスフェート等が挙げられる。
Examples of the phenylmethane triisocyanate include 1-methylbenzene-2,4,6-triisocyanate, 1,3,5-trimethylbenzene-2,4,6-triisocyanate and 1,3,7-naphthalentry. Isocyanate, biphenyl-2,4,4'-triisocyanate, diphenylmethane-2,4,4'-triisocyanate, 3-methyldiphenylmethane-4,6,4'-triisocyanate, triphenylmethane-4,4', 4''-Triisocyanate, 1,6,11-Undecantryisocyanate, 1,8-diisocyanate-4-isocyanatemethyloctane, 1,3,6-hexamethylenetriisocyanate, bicycloheptane triisocyanate, tris (isocyanatephenyl) Thiophosphate and the like can be mentioned.
また、これらのポリイソシアネート化合物のダイマー、トリマー(イソシアヌレート結合)で用いられてもよく、また、アミンと反応させてビウレットとして用いてもよい。
Further, it may be used as a dimer or trimmer (isocyanurate bond) of these polyisocyanate compounds, or may be reacted with an amine and used as a biuret.
さらに、これらのポリイソシアネート化合物と、ポリオールを反応させたウレタン結合を有するポリイソシアネートも用いることができる。ポリオールとしては、2~8価のものが好ましく、前述のポリオールが好ましい。なお、R3-(NCO)h+1として3価以上のポリイソシアネートを用いる場合は、このウレタン結合を有するポリイソシアネートが好ましい。
Further, a polyisocyanate having a urethane bond obtained by reacting these polyisocyanate compounds with a polyol can also be used. As the polyol, those having a valence of 2 to 8 are preferable, and the above-mentioned polyol is preferable. When a polyisocyanate having a valence of 3 or more is used as R 3- (NCO) h + 1 , the polyisocyanate having this urethane bond is preferable.
上記式HO-(R4-O)n-R5で表されるポリエーテルモノアルコールは、直鎖および分岐鎖または2級の1価アルコールのポリエーテルであれば特に限定されない。このような化合物は、直鎖および分岐鎖または2級の1価アルコールにエチレンオキシド、プロピレンオキシド、ブチレンオキシド、エピクロルヒドリン等のアルキレンオキシド、スチレンオキシド等を付加重合することにより得ることができる。
The polyether monoalcohol represented by the above formula HO- (R 4 -O) n -R 5 is not particularly limited as long as it is a linear and branched chain or a secondary monohydric alcohol polyether. Such compounds can be obtained by addition polymerization of ethylene oxide, propylene oxide, butylene oxide, alkylene oxide such as epichlorohydrin, styrene oxide and the like to linear and branched chain or secondary monohydric alcohols.
ここでいう直鎖アルコールとは、下記式(II)で表される。
R6-OH (II) The linear alcohol referred to here is represented by the following formula (II).
R 6 -OH (II)
R6-OH (II) The linear alcohol referred to here is represented by the following formula (II).
R 6 -OH (II)
また、ここでいう分岐鎖アルコールとは、下記式(III)で表される。
Further, the branched chain alcohol referred to here is represented by the following formula (III).
したがって、R5は、上記式(II)~(IV)において水酸基を除いた基である。上記式(II)~(IV)においてR6、R7、R8、R10およびR11は炭化水素基またはフッ素炭素基であり、例えば、アルキル基、アルケニル基、アルキルアリール基、シクロアルキル基、シクロアルケニル基等である。
Therefore, R 5 is a group excluding the hydroxyl group in the above formulas (II) to (IV). In the above formulas (II) to (IV), R 6 , R 7 , R 8 , R 10 and R 11 are hydrocarbon groups or fluorocarbon groups, for example, an alkyl group, an alkenyl group, an alkylaryl group and a cycloalkyl group. , Cycloalkyl group, etc.
アルキル基としては、例えば、メチル、エチル、プロピル、イソプロピル、ブチル、イソブチル、ターシャリブチル、ペンチル、イソペンチル、ネオペンチル、ターシャリペンチル、ヘキシル、ヘプチル、オクチル、2-エチルヘキシル、ノニル、デシル、ウンデシル、ドデシル、トリデシル、イソトリデシル、ミリスチル、パルミチル、ステアリル、イソステアリル、イコシル、ドコシル、テトラコシル、トリアコンチル、2-オクチルドデシル、2-ドデシルヘキサデシル、2-テトラデシルオクタデシル、モノメチル分岐-イソステアリル等が挙げられる。
Examples of the alkyl group include methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tertiarybutyl, pentyl, isopentyl, neopentyl, tertiarypentyl, hexyl, heptyl, octyl, 2-ethylhexyl, nonyl, decyl, undecyl and dodecyl. , Tridecyl, Isotridecyl, Myristyl, Palmytyl, Stearyl, Isostearyl, Icosyl, Docosyl, Tetracosyl, Triacontyl, 2-octyldodecyl, 2-Dodecylhexadecyl, 2-Tetradecyl octadecyl, monomethyl branched-isostearyl and the like.
アルケニル基としては、例えば、ビニル、アリル、プロペニル、イソプロペニル、ブテニル、ペンテニル、イソペンテニル、ヘキセニル、ヘプテニル、オクテニル、ノネニル、デセニル、ウンデセニル、ドデセニル、テトラデセニル、オレイル等が挙げられる。
Examples of the alkenyl group include vinyl, allyl, propenyl, isopropenyl, butenyl, pentenyl, isopentenyl, hexenyl, heptenyl, octenyl, nonenyl, decenyl, undecenyl, dodecenyl, tetradecenyl, oleyl and the like.
アルキルアリール基としては、フェニル、トルイル、キシリル、クメニル、メシチル、ベンジル、フェネチル、スチリル、シンナミル、ベンズヒドリル、トリチル、エチルフェニル、プロピルフェニル、ブチルフェニル、ペンチルフェニル、ヘキシルフェニル、ヘプチルフェニル、オクチルフェニル、ノニルフェニル、α-ナフチル、β-ナフチル基等が挙げられる。
Examples of the alkylaryl group include phenyl, toluyl, xylyl, cumenyl, mesityl, benzyl, phenethyl, styryl, cinnamyl, benzhydryl, trityl, ethylphenyl, propylphenyl, butylphenyl, pentylphenyl, hexylphenyl, heptylphenyl, octylphenyl and nonyl. Examples thereof include phenyl, α-naphthyl, β-naphthyl group and the like.
シクロアルキル基、シクロアルケニル基としては、例えば、シクロペンチル、シクロヘキシル、シクロヘプチル、メチルシクロペンチル、メチルシクロヘキシル、メチルシクロヘプチル、シクロペンテニル、シクロヘキセニル、シクロヘプテニル、メチルシクロペンテニル、メチルシクロヘキセニル、メチルシクロヘプテニル基等が挙げられる。
Examples of the cycloalkyl group and the cycloalkenyl group include cyclopentyl, cyclohexyl, cycloheptyl, methylcyclopentyl, methylcyclohexyl, methylcycloheptyl, cyclopentenyl, cyclohexenyl, cycloheptenyl, methylcyclopentenyl, methylcyclohexenyl and methylcycloheptenyl groups. And so on.
上記式(III)において、R9は炭化水素基、またはフッ化炭素基であり、例えば、アルキレン基、アルケニレン基、アルキルアリーレン基、シクロアルキレン基、シクロアルケニレン基等である。
In the above formula (III), R 9 is a hydrocarbon group or a fluorocarbon group, for example, an alkylene group, an alkenylene group, an alkylarylene group, a cycloalkylene group, a cycloalkenylene group and the like.
また、R5は、炭化水素基またはフッ化炭素基であり、そのうちアルキル基であることが好ましく、さらにその合計の炭素原子数が8~36が好ましく、12~24が特に好ましい。
Further, R 5 is a hydrocarbon group or a fluorocarbon group, of which an alkyl group is preferable, and the total number of carbon atoms thereof is preferably 8 to 36, particularly preferably 12 to 24.
また、付加させるアルキレンオキシド、スチレンオキシド等は、単独重合、2種以上のランダム重合あるいはブロック重合であってよい。付加の方法は通常の方法であってよい。重合度nは0~1000であり、好ましくは1~200、さらに好ましくは10~200が良い。また、R4に占めるエチレン基の割合が、好ましくは全R4の50~100質量%、さらに好ましくは、65~100質量%であることが望ましい。
Further, the alkylene oxide, styrene oxide and the like to be added may be homopolymerized, two or more kinds of random polymerization or block polymerization. The method of addition may be a normal method. The degree of polymerization n is 0 to 1000, preferably 1 to 200, and more preferably 10 to 200. Further, it is desirable that the ratio of the ethylene group to R 4 is preferably 50 to 100% by mass, more preferably 65 to 100% by mass of the total R 4 .
上記式(I)で表されるコポリマーを製造する方法としては、通常のポリエーテルとイソシアネートとの反応と同様にして、例えば、80~90℃で1~3時間加熱し、反応せしめて得ることができる。
As a method for producing the copolymer represented by the above formula (I), the copolymer may be obtained by heating at 80 to 90 ° C. for 1 to 3 hours in the same manner as the reaction between ordinary polyether and isocyanate and reacting. Can be done.
また、R1-[(O-R2)k-OH]mで表されるポリエーテルポリオール(a)と、R3-(NCO)h+1で表されるポリイソシアネート(b)と、HO-(R4-O)n-R5で表されるポリエーテルモノアルコール(c)とを反応させる場合には、式(I)の構造のコポリマー以外のものも副生することがある。例えば、ジイソシアネートを用いた場合、主生成物としては式(I)で表されるc-b-a-b-c型のコポリマーが生成するが、その他、c-b-c型、c-b-(a-b)x-a-b-c型等のコポリマーが副生することがある。この場合、特に式(I)型のコポリマーを分離することなく、式(I)型のコポリマーを含む混合物の状態で本発明に使用することができる。
Further, the polyether polyol (a) represented by R 1 − [(OR 2 ) k − OH] m , the polyisocyanate (b) represented by R 3- (NCO) h + 1 , and HO. -When reacting with the polyether monoalcohol (c) represented by (R 4 -O) n-R 5 , other than the copolymer having the structure of the formula (I) may be produced as a by-product. For example, when diisocyanate is used, the main product is a c-b-a-bc-type copolymer represented by the formula (I), but in addition, c-bc-type and c-b are produced. -(A-b) x -ab-c type copolymers may be produced as by-products. In this case, it can be used in the present invention in the form of a mixture containing the copolymer of the formula (I) without separating the copolymer of the formula (I) in particular.
特に好ましい例として、INCI名称が「(PEG-240/デシルテトラデセス-20/HDI)コポリマー(PEG-240/HDI COPOLYMER BISDECYLTETRADECETH-20 ETHER)」である疎水変性ポリエーテルウレタンが挙げられる。当該コポリマーは、商品名「アデカノールGT-700」として株式会社ADEKAから市販されている。
A particularly preferable example is a hydrophobically modified polyether urethane having an INCI name of "(PEG-240 / decyltetradeceth-20 / HDI) copolymer (PEG-240 / HDI COPOLYMER BISDECYLTETRADECETH-20 ETHER)". The copolymer is commercially available from ADEKA Corporation under the trade name "ADEKANOR GT-700".
(A)疎水変性ポリエーテルウレタンの配合量は、基剤全量に対して、好ましくは0.1~3質量%、より好ましくは0.3~2.5質量%、さらには0.5~3質量%であることが望ましい。配合量が0.1質量%以上であることで、基剤の粘度をより低減させることなく(B)塩型美白薬剤を含有させることができ、シートを剥がした後でもよりもちもちとした独特の感触がより得られ、3質量%以下であることで、より肌に対するシートの密着性がよく、剥がした後によりべたつきがないものとするができる。
(A) The blending amount of the hydrophobically modified polyether urethane is preferably 0.1 to 3% by mass, more preferably 0.3 to 2.5% by mass, and further 0.5 to 3 with respect to the total amount of the base. It is preferably by mass%. When the blending amount is 0.1% by mass or more, the (B) salt-type whitening agent can be contained without further reducing the viscosity of the base, and it is unique and chewy even after the sheet is peeled off. When the feel is more obtained and the content is 3% by mass or less, the sheet has better adhesion to the skin and can be made less sticky after being peeled off.
(B)塩型美白薬剤
(B)塩型美白薬剤は、塩を形成可能な水溶性の薬剤を意味し、塩を形成した状態の美白薬剤であってもよいし、他の化合物と反応して塩を形成することが可能である美白薬剤であってもよい。水溶性薬剤であれば特に制限がなく希望する薬剤を配合することができる。例えば、L-アスコルビン酸およびその誘導体の塩、トラネキサム酸およびその誘導体の塩、アルコキシサリチル酸およびその誘導体の塩、グルタチオンおよびその誘導体の塩などが好ましいものとして挙げられる。 (B) Salt-type whitening agent (B) Salt-type whitening agent means a water-soluble agent capable of forming a salt, and may be a whitening agent in a salt-formed state or reacts with other compounds. It may be a whitening agent capable of forming a salt. As long as it is a water-soluble drug, the desired drug can be blended without particular limitation. For example, salts of L-ascorbic acid and its derivatives, salts of tranexamic acid and its derivatives, salts of alkoxysalicylic acid and its derivatives, salts of glutathione and its derivatives, and the like are preferred.
(B)塩型美白薬剤は、塩を形成可能な水溶性の薬剤を意味し、塩を形成した状態の美白薬剤であってもよいし、他の化合物と反応して塩を形成することが可能である美白薬剤であってもよい。水溶性薬剤であれば特に制限がなく希望する薬剤を配合することができる。例えば、L-アスコルビン酸およびその誘導体の塩、トラネキサム酸およびその誘導体の塩、アルコキシサリチル酸およびその誘導体の塩、グルタチオンおよびその誘導体の塩などが好ましいものとして挙げられる。 (B) Salt-type whitening agent (B) Salt-type whitening agent means a water-soluble agent capable of forming a salt, and may be a whitening agent in a salt-formed state or reacts with other compounds. It may be a whitening agent capable of forming a salt. As long as it is a water-soluble drug, the desired drug can be blended without particular limitation. For example, salts of L-ascorbic acid and its derivatives, salts of tranexamic acid and its derivatives, salts of alkoxysalicylic acid and its derivatives, salts of glutathione and its derivatives, and the like are preferred.
L-アスコルビン酸は、一般にビタミンCと言われ、強い還元作用により細胞呼吸作用、酵素賦活作用、膠原形成作用を有し、かつメラニン還元作用を有する。L-アスコルビン酸誘導体としては、L-アスコルビン酸モノステアレート、L-アスコルビン酸モノパルミテート、L-アスコルビン酸モノオレートなどのL-アスコルビン酸モノアルキルエステル類;L-アスコルビン酸モノリン酸エステル、L-アスコルビン酸-2-硫酸エステルなどのL-アスコルビン酸モノエステル類;L-アスコルビン酸ジステアレート、L-アスコルビン酸ジパルミテート、L-アスコルビン酸ジオレートなどのL-アスコルビン酸ジアルキルエステル類;L-アスコルビン酸トリステアレート、L-アスコルビン酸トリパルミテート、L-アスコルビン酸トリオレートなどのL-アスコルビン酸トリアルキルエステル類;L-アスコルビン酸トリリン酸エステルなどのL-アスコルビン酸トリエステル類;L-アスコルビン酸2-グルコシドなどのL-アスコルビン酸グルコシド類などが挙げられる。本発明では、L-アスコルビン酸、L-アスコルビン酸リン酸エステル、L-アスコルビン酸-2-硫酸エステル、L-アスコルビン酸2-グルコシド、アスコルビン酸リン酸マグネシウムの各塩の形で好適に用いられる。
L-ascorbic acid is generally called vitamin C, and has a cellular respiration effect, an enzyme activating effect, a collagen forming effect, and a melanin reducing effect due to a strong reducing action. Examples of the L-ascorbic acid derivative include L-ascorbic acid monoalkyl esters such as L-ascorbic acid monostearate, L-ascorbic acid monopalmitate, and L-ascorbic acid monoolate; L-ascorbic acid monophosphate ester, L-. L-ascorbic acid monoesters such as ascorbic acid-2-sulfate ester; L-ascorbic acid dialkyl esters such as L-ascorbic acid distearate, L-ascorbic acid dipalmitate, L-ascorbic acid dioleate; L-ascorbic acid tristeer L-ascorbic acid trialkyl esters such as rate, L-ascorbic acid tripalmitate, L-ascorbic acid triolate; L-ascorbic acid triesters such as L-ascorbic acid triphosphate; L-ascorbic acid 2- Examples thereof include L-ascorbic acid glucosides such as glucoside. In the present invention, it is preferably used in the form of salts of L-ascorbic acid, L-ascorbic acid phosphate ester, L-ascorbic acid-2-sulfate ester, L-ascorbic acid 2-glucoside, and magnesium ascorbic acid phosphate. ..
トラネキサム酸誘導体としては、トラネキサム酸の二量体、(例えば、塩酸トランス-4-(トランス-アミノメチルシクロヘキサンカルボニル)アミノメチルシクロヘキサンカルボン酸、等)、トラネキサム酸とハイドロキノンのエステル体(例えば、4-(トランス-アミノメチルシクロヘキサンカルボン酸4’-ヒドロキシフェニルエステル、等)、トラネキサム酸とゲンチシン酸のエステル体(例えば、2-(トランス-4-アミノメチルシクロヘキシルカルボニルオキシ)-5-ヒドロキシ安息香酸、等)、トラネキサム酸のアミド体(例えば、トランス-4-アミノメチルシクロヘキサンカルボン酸メチルアミド、トランス-4-(p-メトキシベンゾイル)アミノメチルシクロヘキサンカルボン酸、トランス-4-グアニジノメチルシクロヘキサンカルボン酸、等)などが挙げられる。本発明ではトラネキサム酸の塩あるいはトラネキサム酸誘導体の塩の形で好適に用いられる。
Examples of the tranexamic acid derivative include a dimer of tranexamic acid (eg, trans-4- (trans-aminomethylcyclohexanecarbonyl) aminomethylcyclohexanecarboxylic acid, etc.), an ester of tranexamic acid and hydroquinone (eg, 4-). (Trans-aminomethylcyclohexanecarboxylic acid 4'-hydroxyphenyl ester, etc.), ester of tranexamic acid and gentisic acid (eg, 2- (trans-4-aminomethylcyclohexylcarbonyloxy) -5-hydroxybenzoic acid, etc.) ), Amido form of tranexamic acid (eg, trans-4-aminomethylcyclohexanecarboxylic acid methylamide, trans-4- (p-methoxybenzoyl) aminomethylcyclohexanecarboxylic acid, trans-4-guanidinomethylcyclohexanecarboxylic acid, etc.), etc. In the present invention, it is preferably used in the form of a salt of tranexamic acid or a salt of a tranexamic acid derivative.
アルコキシサリチル酸は、サリチル酸の3位、4位または5位のいずれかの水素原子がアルコキシ基にて置換されたものであり、置換基であるアルコキシ基は、好ましくはメトキシ基、エトキシ基、プロポキシ基、イソプロポキシ基、ブトキシ基、イソブトキシ基のいずれかであり、さらに好ましくはメトキシ基またはエトキシ基である。具体的に化合物名を例示すれば、3-メトキシサリチル酸、3-エトキシサリチル酸、4-メトキシサリチル酸、4-エトキシサリチル酸、4-プロポキシサリチル酸、4-イソプロポキシサリチル酸、4-ブトキシサリチル酸、5-メトキシサリチル酸、5-エトキシサリチル酸、5-プロポキシサリチル酸などが挙げられる。本発明ではアルコキシサリチル酸およびその誘導体(エステルなど)の各塩の形で好適に用いられる。
Alkoxysalicylic acid is obtained by substituting a hydrogen atom at any of the 3-position, 4-position or 5-position of salicylic acid with an alkoxy group, and the alkoxy group as a substituent is preferably a methoxy group, an ethoxy group or a propoxy group. , An isopropoxy group, a butoxy group, or an isobutoxy group, more preferably a methoxy group or an ethoxy group. Specific examples of compound names include 3-methoxysalicylic acid, 3-ethoxysalicylic acid, 4-methoxysalicylic acid, 4-ethoxysalicylic acid, 4-propoxysalicylic acid, 4-isopropoxysalicylic acid, 4-butoxysalicylic acid, and 5-methoxysalicylic acid. , 5-ethoxysalicylic acid, 5-propoxysalicylic acid and the like. In the present invention, it is preferably used in the form of each salt of alkoxysalicylic acid and its derivatives (esters, etc.).
上記薬剤の塩としては、特に限定されないが、例えば、ナトリウム塩、カリウム塩、カルシウム塩のようなアルカリ金属塩またはアルカリ土類金属塩のほか、アンモニウム塩、アミノ酸塩等の塩が挙げられる。
特に、4-メトキシサリチル酸カリウム塩またはアスコルビン酸グルコシドが好ましく用いられる。 The salt of the above-mentioned drug is not particularly limited, and examples thereof include alkali metal salts such as sodium salt, potassium salt and calcium salt, alkaline earth metal salts, and salts such as ammonium salt and amino acid salt.
In particular, 4-methoxysalicylic acid potassium salt or ascorbic acid glucoside is preferably used.
特に、4-メトキシサリチル酸カリウム塩またはアスコルビン酸グルコシドが好ましく用いられる。 The salt of the above-mentioned drug is not particularly limited, and examples thereof include alkali metal salts such as sodium salt, potassium salt and calcium salt, alkaline earth metal salts, and salts such as ammonium salt and amino acid salt.
In particular, 4-methoxysalicylic acid potassium salt or ascorbic acid glucoside is preferably used.
(B)塩型美白薬剤は、1種または2種以上を用いることができ、その配合量は任意であり、用いる(B)塩型美白薬剤にもよるため一概にはいえないが、基剤全量に対して、0.001~3質量%が好ましく、さらには0.05~2質量%であることが望ましい。0.001質量%以上であることで、美白効果をより実現することができ、3質量%以下であることで使用性を良好なものとすることができる。
As the (B) salt-type whitening agent, one type or two or more types can be used, and the blending amount thereof is arbitrary, and it cannot be said unconditionally because it depends on the (B) salt-type whitening agent to be used, but it is a base. It is preferably 0.001 to 3% by mass, more preferably 0.05 to 2% by mass, based on the total amount. When it is 0.001% by mass or more, the whitening effect can be further realized, and when it is 3% by mass or less, the usability can be improved.
(B)塩型美白薬剤に対する(A)疎水変性ポリエーテルウレタンの質量比は0.2~1であることが好ましく、0.3~0.8であることがより好ましい。(B)塩型美白薬剤に対する(A)疎水変性ポリエーテルウレタンの質量比が0.3以上であることで、基剤の粘度をより低減させることなく(B)塩型美白薬剤を含有させることができ、シートを剥がした後でもよりもちもちとした独特の感触がより得られ、質量比が1以下であることで、より肌に対するシートの密着性がよく、剥がした後によりべたつきがないものとするができる。
The mass ratio of (A) hydrophobically modified polyether urethane to (B) salt-type whitening agent is preferably 0.2 to 1, and more preferably 0.3 to 0.8. (B) The mass ratio of the (A) hydrophobically modified polyether urethane to the salt-type whitening agent is 0.3 or more, so that the (B) salt-type whitening agent is contained without further reducing the viscosity of the base. The sheet has a more chewy and unique feel even after the sheet is peeled off, and the mass ratio is 1 or less, so that the sheet has better adhesion to the skin and is less sticky after being peeled off. Can be done.
(C)カルボキシビニルポリマー
本発明の基剤には、(C)カルボキシビニルポリマーを含むことが好ましい。
(C)カルボキシビニルポリマー(カルボマー)は、カルボキシル基を有する水溶性のビニルポリマーであり、具体的には、アクリル酸および/またはメタクリル酸を主鎖とするポリマーである。カルボキシビニルポリマーの市販品としては、Carbopol 940、Carbopol 941、Carbopol 980、Carbopol 981(いずれもルブリゾール社製)等を使用することができる。 (C) Carboxyvinyl Polymer The base of the present invention preferably contains (C) carboxyvinyl polymer.
(C) The carboxyvinyl polymer (carbomer) is a water-soluble vinyl polymer having a carboxyl group, and specifically, a polymer having acrylic acid and / or methacrylic acid as a main chain. As a commercially available product of the carboxyvinyl polymer, Carbopol 940, Carbopol 941, Carbopol 980, Carbopol 981 (all manufactured by Lubrizol) and the like can be used.
本発明の基剤には、(C)カルボキシビニルポリマーを含むことが好ましい。
(C)カルボキシビニルポリマー(カルボマー)は、カルボキシル基を有する水溶性のビニルポリマーであり、具体的には、アクリル酸および/またはメタクリル酸を主鎖とするポリマーである。カルボキシビニルポリマーの市販品としては、Carbopol 940、Carbopol 941、Carbopol 980、Carbopol 981(いずれもルブリゾール社製)等を使用することができる。 (C) Carboxyvinyl Polymer The base of the present invention preferably contains (C) carboxyvinyl polymer.
(C) The carboxyvinyl polymer (carbomer) is a water-soluble vinyl polymer having a carboxyl group, and specifically, a polymer having acrylic acid and / or methacrylic acid as a main chain. As a commercially available product of the carboxyvinyl polymer, Carbopol 940, Carbopol 941, Carbopol 980, Carbopol 981 (all manufactured by Lubrizol) and the like can be used.
(C)カルボキシビニルポリマーの配合量は0.01~1質量%が好ましく、さらに好ましくは0.05~0.8質量%、さらには0.1~0.5質量%であることが望ましい。(C)カルボキシビニルポリマーの配合量が0.01質量%以上であることで、静置粘度をより充分なものすることができるので、基剤のクリーミングを防ぎ安定的に保つことができる。また1質量%以下であることで、より肌に対するシートの密着性がよく、剥がした後によりべたつきがないものとするができる。
The blending amount of the (C) carboxyvinyl polymer is preferably 0.01 to 1% by mass, more preferably 0.05 to 0.8% by mass, and further preferably 0.1 to 0.5% by mass. When the blending amount of the (C) carboxyvinyl polymer is 0.01% by mass or more, the static viscosity can be made more sufficient, so that creaming of the base can be prevented and stable can be maintained. Further, when it is 1% by mass or less, the adhesion of the sheet to the skin is better, and it can be made less sticky after peeling.
(D)ポリオキシエチレン脂肪酸グリセリルまたはポリオキシエチレン硬化ヒマシ油
本発明の基剤には、(D)ポリオキシエチレン脂肪酸グリセリルまたはポリオキシエチレン硬化ヒマシ油を含むことが好ましい。
(D)ポリオキシエチレン脂肪酸グリセリルまたはポリオキシエチレン硬化ヒマシ油は少なくともいずれかを含めばよく、両方を含んでいてもよい。 (D) Polyoxyethylene fatty acid glyceryl or polyoxyethylene hydrogenated castor oil The base of the present invention preferably contains (D) polyoxyethylene fatty acid glyceryl or polyoxyethylene hydrogenated castor oil.
(D) The polyoxyethylene fatty acid glyceryl or the polyoxyethylene hydrogenated castor oil may contain at least one of them, and may contain both of them.
本発明の基剤には、(D)ポリオキシエチレン脂肪酸グリセリルまたはポリオキシエチレン硬化ヒマシ油を含むことが好ましい。
(D)ポリオキシエチレン脂肪酸グリセリルまたはポリオキシエチレン硬化ヒマシ油は少なくともいずれかを含めばよく、両方を含んでいてもよい。 (D) Polyoxyethylene fatty acid glyceryl or polyoxyethylene hydrogenated castor oil The base of the present invention preferably contains (D) polyoxyethylene fatty acid glyceryl or polyoxyethylene hydrogenated castor oil.
(D) The polyoxyethylene fatty acid glyceryl or the polyoxyethylene hydrogenated castor oil may contain at least one of them, and may contain both of them.
(ポリオキシエチレン脂肪酸グリセリル)
ポリオキシエチレン脂肪酸グリセリルとしては、例えば、(モノ)イソステアリン酸PEG-8グリセリル、(モノ)イソステアリン酸PEG-20グリセリル、(モノ)イソステアリン酸PEG-60グリセリル、トリイソステアリン酸PEG-20グリセリル、ヤシ油脂肪酸PEG-7グリセリルが挙げられる。
ポリオキシエチレン脂肪酸グリセリルは、ポリオキシエチレンの付加モル数が5~20であるものが好ましい。 (Polyoxyethylene fatty acid glyceryl)
Examples of the polyoxyethylene fatty acid glyceryl include (mono) PEG-8 glyceryl isostearate, (mono) PEG-20 glyceryl isostearate, (mono) PEG-60 glyceryl isostearate, PEG-20 glyceryl triisostearate, and coconut oil. Examples include the fatty acid PEG-7 glyceryl.
The polyoxyethylene fatty acid glyceryl preferably has 5 to 20 moles of polyoxyethylene added.
ポリオキシエチレン脂肪酸グリセリルとしては、例えば、(モノ)イソステアリン酸PEG-8グリセリル、(モノ)イソステアリン酸PEG-20グリセリル、(モノ)イソステアリン酸PEG-60グリセリル、トリイソステアリン酸PEG-20グリセリル、ヤシ油脂肪酸PEG-7グリセリルが挙げられる。
ポリオキシエチレン脂肪酸グリセリルは、ポリオキシエチレンの付加モル数が5~20であるものが好ましい。 (Polyoxyethylene fatty acid glyceryl)
Examples of the polyoxyethylene fatty acid glyceryl include (mono) PEG-8 glyceryl isostearate, (mono) PEG-20 glyceryl isostearate, (mono) PEG-60 glyceryl isostearate, PEG-20 glyceryl triisostearate, and coconut oil. Examples include the fatty acid PEG-7 glyceryl.
The polyoxyethylene fatty acid glyceryl preferably has 5 to 20 moles of polyoxyethylene added.
ポリオキシエチレン脂肪酸グリセリルの市販品としては、ポリオキシエチレン(8)モノイソステアリン酸グリセリルであるエマレックスGWIS-108(日本エマルジョン株社製)、(モノ)イソステアリン酸PEG-20グリセリルであるエマレックスGWIS-120(同)、ポリオキシエチレン(60)モノイソステアリン酸グリセリルであるエマレックスGWIS-160(同)、ポリオキシエチレン(20)トリイソステアリン酸グリセリルであるエマレックスGWIS-320(同)、PEG-7ヤシ油脂肪酸グリセリルであるセチオールHE(コグニスジャパン株社製)やグリセロックスHE(CRODA社)等が挙げられる。
Commercially available products of polyoxyethylene fatty acid glyceryl include Emarex GWIS-108 (manufactured by Nippon Emulsion Co., Ltd.), which is polyoxyethylene (8) glyceryl monoisostearate, and Emarex GWIS, which is PEG-20 glyceryl (mono) isostearate. -120 (same as above), Emarex GWIS-160 (same as above), which is glyceryl monoisostearate of polyoxyethylene (60), Emarex GWIS-320 (same as above), which is glyceryl of polyoxyethylene (20) triisostearate, PEG- 7 Palm oil fatty acid glyceryl such as cethiol HE (manufactured by Cognis Japan Co., Ltd.) and glycerox HE (manufactured by CRODA).
(ポリオキシエチレン硬化ヒマシ油)
ポリオキシエチレン硬化ヒマシ油は、親水性であることが好ましく、エチレンオキシドの平均付加モル数が30~100、さらには40~80であることが好ましい。
ポリオキシエチレン硬化ヒマシ油の市販品としては、PEG30水添ヒマシ油であるニッコールHCO-30、PEG40水添ヒマシ油であるニッコールHCO-40、PEG60水添ヒマシ油であるニッコールHCO-60、PEG100水添ヒマシ油であるニッコールHCO-100等(いずれも日光ケミカルズ株社製)が挙げられる。このうち、PEG60水添ヒマシ油を特に好適に用いることができる。 (Polyoxyethylene hydrogenated castor oil)
The polyoxyethylene hydrogenated castor oil is preferably hydrophilic, and the average number of moles of ethylene oxide added is preferably 30 to 100, more preferably 40 to 80.
Commercially available products of polyoxyethylene cured castor oil include Nikkor HCO-30, which is PEG30 hydrogenated castor oil, Nikkor HCO-40, which is PEG40 hydrogenated castor oil, Nikkor HCO-60, which is PEG60 hydrogenated castor oil, and PEG100 water. Examples thereof include Nikkor HCO-100, which is a castor oil, (all manufactured by Nikko Chemicals Co., Ltd.). Of these, PEG60 hydrogenated castor oil can be particularly preferably used.
ポリオキシエチレン硬化ヒマシ油は、親水性であることが好ましく、エチレンオキシドの平均付加モル数が30~100、さらには40~80であることが好ましい。
ポリオキシエチレン硬化ヒマシ油の市販品としては、PEG30水添ヒマシ油であるニッコールHCO-30、PEG40水添ヒマシ油であるニッコールHCO-40、PEG60水添ヒマシ油であるニッコールHCO-60、PEG100水添ヒマシ油であるニッコールHCO-100等(いずれも日光ケミカルズ株社製)が挙げられる。このうち、PEG60水添ヒマシ油を特に好適に用いることができる。 (Polyoxyethylene hydrogenated castor oil)
The polyoxyethylene hydrogenated castor oil is preferably hydrophilic, and the average number of moles of ethylene oxide added is preferably 30 to 100, more preferably 40 to 80.
Commercially available products of polyoxyethylene cured castor oil include Nikkor HCO-30, which is PEG30 hydrogenated castor oil, Nikkor HCO-40, which is PEG40 hydrogenated castor oil, Nikkor HCO-60, which is PEG60 hydrogenated castor oil, and PEG100 water. Examples thereof include Nikkor HCO-100, which is a castor oil, (all manufactured by Nikko Chemicals Co., Ltd.). Of these, PEG60 hydrogenated castor oil can be particularly preferably used.
(D)成分の配合量は0.01~1質量%が好ましく、さらに好ましくは0.05~0.8質量%、さらには0.08~0.5質量%であることが望ましい。(D)成分の配合量が0.01質量%以上であることで、シートを触った時のぷるぷるとした感触をより保つことができ、かつ乳化安定性もより向上させることができる。また1質量%以下であることで、より肌に対するシートの密着性がよく、剥がした後によりべたつきがないものとすることができる。
The blending amount of the component (D) is preferably 0.01 to 1% by mass, more preferably 0.05 to 0.8% by mass, and further preferably 0.08 to 0.5% by mass. When the blending amount of the component (D) is 0.01% by mass or more, the fluffy feel when the sheet is touched can be further maintained, and the emulsification stability can be further improved. Further, when it is 1% by mass or less, the adhesion of the sheet to the skin is better, and it can be made less sticky after peeling.
(E)高級脂肪酸
本発明の基剤には、(E)高級脂肪酸を含むことが好ましい。
(E)高級脂肪酸は、直鎖状または分岐鎖状の、飽和または不飽和の炭化水素基を有する炭素原子数12~22の高級脂肪酸であって、常温(25℃)で液状のものであることが好ましい。例えば、オレイン酸、リノール酸、リノレン酸等の直鎖脂肪酸や、イソステアリン酸、イソパルミチン酸等の分岐鎖脂肪酸が挙げられる。特にイソステアリン酸が好ましく使用できる。 (E) Higher fatty acid The base of the present invention preferably contains (E) higher fatty acid.
(E) The higher fatty acid is a linear or branched higher fatty acid having a saturated or unsaturated hydrocarbon group and having 12 to 22 carbon atoms, and is liquid at room temperature (25 ° C.). Is preferable. Examples thereof include linear fatty acids such as oleic acid, linoleic acid and linolenic acid, and branched chain fatty acids such as isostearic acid and isoparmitic acid. In particular, isostearic acid can be preferably used.
本発明の基剤には、(E)高級脂肪酸を含むことが好ましい。
(E)高級脂肪酸は、直鎖状または分岐鎖状の、飽和または不飽和の炭化水素基を有する炭素原子数12~22の高級脂肪酸であって、常温(25℃)で液状のものであることが好ましい。例えば、オレイン酸、リノール酸、リノレン酸等の直鎖脂肪酸や、イソステアリン酸、イソパルミチン酸等の分岐鎖脂肪酸が挙げられる。特にイソステアリン酸が好ましく使用できる。 (E) Higher fatty acid The base of the present invention preferably contains (E) higher fatty acid.
(E) The higher fatty acid is a linear or branched higher fatty acid having a saturated or unsaturated hydrocarbon group and having 12 to 22 carbon atoms, and is liquid at room temperature (25 ° C.). Is preferable. Examples thereof include linear fatty acids such as oleic acid, linoleic acid and linolenic acid, and branched chain fatty acids such as isostearic acid and isoparmitic acid. In particular, isostearic acid can be preferably used.
(E)高級脂肪酸の配合量は0.01~3質量%が好ましく、さらに好ましくは0.05~2質量%、さらには0.1~1.5質量%、特には0.2~1質量%であることが望ましい。(D)高級脂肪酸の配合量が0.01質量%以上であることで、より肌に対するシートの密着性がありながらべたつかないものとすることができる。また3質量%以下であることで、シートを剥がした後に肌がぬるつかないものとすることができる。
(E) The blending amount of the higher fatty acid is preferably 0.01 to 3% by mass, more preferably 0.05 to 2% by mass, further 0.1 to 1.5% by mass, and particularly 0.2 to 1% by mass. % Is desirable. (D) When the blending amount of the higher fatty acid is 0.01% by mass or more, the sheet can be made more adherent to the skin but not sticky. Further, when the content is 3% by mass or less, the skin cannot be made slimy after the sheet is peeled off.
(E)高級脂肪酸がイソステアリン酸である場合、(A)疎水変性ポリエーテルウレタンに対するイソステアリン酸の質量比は0.3~1.6であることが好ましい。(A)疎水変性ポリエーテルウレタンに対するイソステアリン酸の質量比が0.3以上であることで、より肌に対するシートの密着性がよく、剥がした後によりべたつきがないものとするができる。また、1.6以下であることで、シートを剥がした後に肌がぬるつかないものとすることができる。
When (E) the higher fatty acid is isostearic acid, the mass ratio of (A) the isostearic acid to the hydrophobically modified polyether urethane is preferably 0.3 to 1.6. (A) When the mass ratio of isostearic acid to the hydrophobically modified polyether urethane is 0.3 or more, the sheet adheres better to the skin and can be made less sticky after being peeled off. Further, when it is 1.6 or less, it is possible to prevent the skin from becoming slimy after the sheet is peeled off.
(F)ジグリセリン
本発明の基剤には、1分子内に水酸基を3個以上有する多価アルコールである(F)ジグリセリンを基剤全量に対し0.2~4質量%含んでいてもよい。(F)ジグリセリンを基剤全量に対し0.2~4質量%の範囲であることで、より肌に対するシートの密着性がよく、剥がした後によりべたつきがないものとするができる。 (F) Diglycerin The base of the present invention contains (F) diglycerin, which is a polyhydric alcohol having three or more hydroxyl groups in one molecule, in an amount of 0.2 to 4% by mass based on the total amount of the base. good. (F) When the amount of diglycerin is in the range of 0.2 to 4% by mass with respect to the total amount of the base, the adhesion of the sheet to the skin is better and the sheet can be made less sticky after being peeled off.
本発明の基剤には、1分子内に水酸基を3個以上有する多価アルコールである(F)ジグリセリンを基剤全量に対し0.2~4質量%含んでいてもよい。(F)ジグリセリンを基剤全量に対し0.2~4質量%の範囲であることで、より肌に対するシートの密着性がよく、剥がした後によりべたつきがないものとするができる。 (F) Diglycerin The base of the present invention contains (F) diglycerin, which is a polyhydric alcohol having three or more hydroxyl groups in one molecule, in an amount of 0.2 to 4% by mass based on the total amount of the base. good. (F) When the amount of diglycerin is in the range of 0.2 to 4% by mass with respect to the total amount of the base, the adhesion of the sheet to the skin is better and the sheet can be made less sticky after being peeled off.
(G)25℃における動粘度が50mm2/s以上のジメチコン
本発明の基剤には、(G)25℃における動粘度が50mm2/s以上のジメチコンを基剤全量に対し2~5質量%含んでいてもよい。(G)成分の配合量が基剤全量に対し2~5質量%の範囲であることで、より肌に対するシートの密着性がよく、剥がした後によりべたつきがないものとするができる。 (G) Dimethicone having a kinematic viscosity of 50 mm 2 / s or more at 25 ° C. The base of the present invention contains (G) dimethicone having a kinematic viscosity of 50 mm 2 / s or more at 25 ° C. in an amount of 2 to 5 mass with respect to the total amount of the base. May be included. When the blending amount of the component (G) is in the range of 2 to 5% by mass with respect to the total amount of the base, the sheet has better adhesion to the skin and can be made less sticky after being peeled off.
本発明の基剤には、(G)25℃における動粘度が50mm2/s以上のジメチコンを基剤全量に対し2~5質量%含んでいてもよい。(G)成分の配合量が基剤全量に対し2~5質量%の範囲であることで、より肌に対するシートの密着性がよく、剥がした後によりべたつきがないものとするができる。 (G) Dimethicone having a kinematic viscosity of 50 mm 2 / s or more at 25 ° C. The base of the present invention contains (G) dimethicone having a kinematic viscosity of 50 mm 2 / s or more at 25 ° C. in an amount of 2 to 5 mass with respect to the total amount of the base. May be included. When the blending amount of the component (G) is in the range of 2 to 5% by mass with respect to the total amount of the base, the sheet has better adhesion to the skin and can be made less sticky after being peeled off.
本発明のシート状化粧料は、上記基剤を不織布に含浸させてなるものである。含浸される不織布は特に限定されないが、天然繊維、再生繊維、合成繊維から選ばれる単繊維または混合繊維の単層または積層であってもよい。例えば、セルロース系繊維(コットン、パルプ、リヨセル、キュプラ、レーヨン、アセテートなど)、アクリル系繊維、ポリエステル系繊維、ポリエチレン、ポリプロピレンなどのポリオレフィン系繊維、ポリウレタン系繊維、ポリアミド系繊維から選ばれる単繊維または混合繊維が好ましく挙げられる。特にポリエステル系繊維とセルロース系繊維の混合繊維が好ましく、コットン、パルプ、ポリエチレンテレフタレートの混合繊維がさらに好ましい。
The sheet-shaped cosmetic of the present invention is obtained by impregnating a non-woven fabric with the above base. The non-woven fabric to be impregnated is not particularly limited, but may be a single layer or a laminate of single fibers or mixed fibers selected from natural fibers, regenerated fibers, and synthetic fibers. For example, a single fiber selected from cellulose fibers (cotton, pulp, lyocell, cupra, rayon, acetate, etc.), acrylic fibers, polyester fibers, polyethylene, polyolefin fibers such as polypropylene, polyurethane fibers, polyamide fibers, etc. Mixed fibers are preferred. In particular, a mixed fiber of polyester fiber and cellulosic fiber is preferable, and a mixed fiber of cotton, pulp and polyethylene terephthalate is more preferable.
シートの厚さは、特に制限はなく、目的に応じて適宜選択することができ、シートが不織布の場合には、0.1~10mmが好ましく、0.1~5mmがより好ましい。また、目付は10~100g/m2が好ましく、30~80g/m2がより好ましい。目付が10g/m2以上であると、使用する際に破けたりすることがなく、また、100g/m2以下であることで、コスト高を抑制することができる。
The thickness of the sheet is not particularly limited and may be appropriately selected depending on the intended purpose. When the sheet is a non-woven fabric, it is preferably 0.1 to 10 mm, more preferably 0.1 to 5 mm. The basis weight is preferably 10 to 100 g / m 2 , more preferably 30 to 80 g / m 2 . If the basis weight is 10 g / m 2 or more, it will not be torn during use, and if it is 100 g / m 2 or less, high cost can be suppressed.
シートの形状は特に限定されるものではなく、例えば、正方形、長方形の他、楕円形、円形、ハート形、半円形、半楕円形、台形、顔型等が挙げられる。
本発明のシート状化粧料において、シートへの基剤の含浸方法は公知の手段により行うことができ、例えば、滴下法、噴霧法、加圧法、ディッピング加工法が挙げられる。シートはそのままあるいは折りたたむなどして1枚または複数枚を用い、これに基剤を含浸させる。不織布に含浸させる基剤の含浸量は特に限定されないが、不織布と基剤の特性に応じて適宜調整し、不織布の質量に対して1.5~25倍の含浸量が好ましい。 The shape of the sheet is not particularly limited, and examples thereof include an ellipse, a circle, a heart shape, a semicircle, a semi-elliptical shape, a trapezoid, and a face shape in addition to a square and a rectangle.
In the sheet-shaped cosmetic of the present invention, the method of impregnating the sheet with the base can be performed by a known means, and examples thereof include a dropping method, a spraying method, a pressurizing method, and a dipping processing method. Use one or more sheets as they are or by folding them, and impregnate them with the base. The impregnation amount of the base to be impregnated into the nonwoven fabric is not particularly limited, but is appropriately adjusted according to the characteristics of the nonwoven fabric and the base, and the impregnation amount is preferably 1.5 to 25 times the mass of the nonwoven fabric.
本発明のシート状化粧料において、シートへの基剤の含浸方法は公知の手段により行うことができ、例えば、滴下法、噴霧法、加圧法、ディッピング加工法が挙げられる。シートはそのままあるいは折りたたむなどして1枚または複数枚を用い、これに基剤を含浸させる。不織布に含浸させる基剤の含浸量は特に限定されないが、不織布と基剤の特性に応じて適宜調整し、不織布の質量に対して1.5~25倍の含浸量が好ましい。 The shape of the sheet is not particularly limited, and examples thereof include an ellipse, a circle, a heart shape, a semicircle, a semi-elliptical shape, a trapezoid, and a face shape in addition to a square and a rectangle.
In the sheet-shaped cosmetic of the present invention, the method of impregnating the sheet with the base can be performed by a known means, and examples thereof include a dropping method, a spraying method, a pressurizing method, and a dipping processing method. Use one or more sheets as they are or by folding them, and impregnate them with the base. The impregnation amount of the base to be impregnated into the nonwoven fabric is not particularly limited, but is appropriately adjusted according to the characteristics of the nonwoven fabric and the base, and the impregnation amount is preferably 1.5 to 25 times the mass of the nonwoven fabric.
基剤を含浸させたシートは、直ちに気密性の高い容器に封入することが好ましく、特にアルミラミネート製包装体やポリエチレンテレフタレート(PET)で内面コートした包装体等の光を通さず、気密の良い袋等に密封装填することがより好ましい。
It is preferable to immediately enclose the sheet impregnated with the base in a highly airtight container, and in particular, the package made of aluminum laminate or the package coated on the inner surface with polyethylene terephthalate (PET) does not allow light to pass through and is airtight. It is more preferable to load it in a bag or the like in a sealed manner.
本発明のシート状化粧料に含浸させる基剤には、上記の(A)~(G)成分以外に、通常化粧品や医薬品等の皮膚外用剤に用いられる成分、例えば、水性成分、油性成分、粉末等を必要に応じて適宜配合することができる。
In addition to the above-mentioned components (A) to (G), the base to be impregnated in the sheet-shaped cosmetic of the present invention includes components usually used for external skin preparations such as cosmetics and pharmaceuticals, for example, an aqueous component and an oily component. Powder and the like can be appropriately blended as needed.
水性成分としては、水や水溶性成分などが挙げられる。水溶性成分としては、例えば低級アルコール、保湿剤、水溶性高分子(天然、半合成、合成、無機)などが挙げられる。なお、水溶性高分子は増粘目的ではない物を指す。
Examples of the aqueous component include water and a water-soluble component. Examples of the water-soluble component include lower alcohols, moisturizers, water-soluble polymers (natural, semi-synthetic, synthetic, inorganic) and the like. The water-soluble polymer refers to a substance that is not intended for thickening.
低級アルコールとしては、エタノール、プロパノール、ブタノール、ペンタノール、ヘキサノールなどが例示される。
Examples of lower alcohols include ethanol, propanol, butanol, pentanol, hexanol and the like.
保湿剤としては、グリセリン、ジエチレングリコール、ブチレングリコール、ポリエチレングリコール、ヘキシレングリコール、キシリトール、ソルビトール、マルチトール、コンドロイチン硫酸、ヒアルロン酸、ムコイチン硫酸、カロニン酸、アテロコラーゲン、エラスチン、アミノ酸、核酸、コレステリル-12-ヒドロキシステアレート、乳酸ナトリウム、胆汁酸塩、dl-ピロリドンカルボン酸塩、短鎖可溶性コラーゲン、ジグリセリン(EO)PO付加物、イサイヨバラ抽出物、セイヨウノキギリソウ抽出物、メリロート抽出物などが例示される。
Moisturizing agents include glycerin, diethylene glycol, butylene glycol, polyethylene glycol, hexylene glycol, xylitol, sorbitol, martitol, chondroitin sulfate, hyaluronic acid, mucoitin sulfate, caronic acid, atelocollagen, elastin, amino acids, nucleic acids, cholesteryl-12-. Examples thereof include hydroxystearate, sodium lactate, bile acid salt, dl-pyrrolidone carboxylate, short chain soluble collagen, diglycerin (EO) PO adduct, isaiyobara extract, sardine extract, melilot extract and the like. To.
天然の水溶性高分子としては、アラアビアガム、トラガカントガム、ガラクタン、グアーガム、ローカストビーンガム、タマリントガム、キャロブガム、カラヤガム、カラギーナン、ペクチン、カンテン、クインスシード(マルメロ)、アルゲコロイド(カッソウエキス)、デンプン(コメ、トウモロコシ、バレイショ、コムギ)、グリチルリチン酸等の植物系水溶性高分子;キサンタンガム、デキストラン、サクシノグリカン、ブルラン等の微生物系水溶性高分子;コラーゲン、カゼイン、アルブミン、ゼラチン等の動物系水溶性高分子などが例示される。
Natural water-soluble polymers include ala-avia gum, tragacanto gum, galactan, guar gum, locust bean gum, tamarint gum, carob gum, karaya gum, carrageenan, pectin, canten, quince seed (malmero), algae colloid (cassow extract), starch (rice, corn). , Potato, wheat), plant-based water-soluble polymers such as glycyrrhizic acid; microbial-based water-soluble polymers such as xanthan gum, dextran, succinoglycan, and burran; animal-based water-soluble polymers such as collagen, casein, albumin, and gelatin. Etc. are exemplified.
半合成水溶性高分子としては、カルボキシメチルデンプン、メチルヒドロキシプロピルデンプン等のデンプン系水溶性高分子;メチルセルロース、ニトロセルロース、エチルセルロース、メチルヒドロキシプロピルセルロース、ヒドロキシエチルセルロース、セルロース硫酸ナトリウム、ヒドロキシプロピルセルロース、カルボキシメチルセルロース(CMC)、結晶セルロース、セルロース末等のセルロース系水溶性高分子;アルギン酸ナトリウム、アルギン酸プロピレングリコールエステル等のアルギン酸系水溶性高分子などが例示される。
Examples of the semi-synthetic water-soluble polymer include starch-based water-soluble polymers such as carboxymethyl starch and methyl hydroxypropyl starch; methyl cellulose, nitrocellulose, ethyl cellulose, methyl hydroxypropyl cellulose, hydroxyethyl cellulose, cellulosic sodium sulfate, hydroxypropyl cellulose, and carboxy. Cellulose-based water-soluble polymers such as methyl cellulose (CMC), crystalline cellulose, and cellulose powder; arginic acid-based water-soluble polymers such as sodium alginate and propylene glycol alginate are exemplified.
合成水溶性高分子としては、ポリビニルアルコール、ポリビニルメチルエーテル、ポリビニルピロリドン等のビニル系水溶性高分子;ポリエチレングリコール20,000、同4,000,000、同600,000等のポリオキシエチレン系水溶性高分子;ポリオキシエチレンポリオキシプロピレン共重合体等の共重合系水溶性高分子;ポリアクリル酸ナトリウム、ポリエチルアクリレート、ポリアクリルアミド等のアクリル系水溶性高分子のほか、ポリエチレンイミン、カチオンポリマーなどが例示される。
Examples of the synthetic water-soluble polymer include vinyl-based water-soluble polymers such as polyvinyl alcohol, polyvinyl methyl ether, and polyvinylpyrrolidone; and polyoxyethylene-based water-soluble polymers such as polyethylene glycol 20,000, 4,000,000, and 600,000. Sexual polymer; Copolymer-based water-soluble polymer such as polyoxyethylene polyoxypropylene copolymer; Acrylic-based water-soluble polymer such as sodium polyacrylate, polyethyl acrylate, and polyacrylamide, as well as polyethyleneimine and cationic polymer. Etc. are exemplified.
無機の水溶性高分子としては、ベントナイト、ケイ酸AlMg(ビーガム)、ラポナイト、ヘクトライト、無水ケイ酸などが例示される。
Examples of the inorganic water-soluble polymer include bentonite, AlMg silicate (bea gum), laponite, hectorite, and silicic acid anhydride.
粉末成分としては、疎水性粉末、親水性粉末のいずれも用いることができる。また、粉末自体が疎水性、親水性のもののみならず、粉末表面を疎水化、親水化の処理をしてもよい。
As the powder component, either hydrophobic powder or hydrophilic powder can be used. Further, not only the powder itself is hydrophobic or hydrophilic, but also the surface of the powder may be hydrophobized or hydrophilized.
粉末成分としては、例えばタルク、カオリン、雲母、絹雲母(セリサイト)、白雲母、金雲母、合成雲母、紅雲母、黒雲母、リチア雲母、パーミキュライト、炭酸マグネシウム、炭酸カルシウム、ケイ酸アルミニウム、ケイ酸バリウム、ケイ酸カルシウム、ケイ酸マグネシウム、ケイ酸ストロンチウム、タングステン酸金属塩、マグネシウム、シリカ、ゼオライト、硫酸バリウム、焼成硫酸カルシウム(焼セッコウ)、リン酸カルシウム、フッ素アパタイト、ヒドロキシアパタイト、セラミックパウダー、金属石鹸(ミリスチン酸亜鉛、パルミチン酸カルシウム、ステアリン酸アルミニウムなど)、ポリアミド樹脂粉末(ナイロン粉末)、ポリエチレン粉末、ポリメタクリル酸メチル粉末、ポリスチレン粉末、スチレンとアクリル酸の共重合体樹脂粉末、ベンゾグアナミン樹脂粉末、ポリ四フッ化エチレン粉末、セルロース粉末などの有機粉末や、トリメチルシルセスキオキサン粉末などのシリコーン粉末、窒化ホウ素等の無機粉末;二酸化チタン、酸化亜鉛等の無機白色顔料;酸化鉄(ベンガラ)、チタン酸鉄等の無機赤色系顔料;γ-酸化鉄等の無機褐色系顔料;黄酸化鉄、黄土等の無機黄色系顔料;黒酸化鉄、カーボンブラック、低次二酸化チタン等の無機黒色系顔料;マンゴバイオレット、バルトバイオレット等の無機紫色系顔料;酸化クロム、水酸化クロム、チタン酸コバルト等の無機緑色系顔料;群青、紺青等の無機青色系顔料;二酸化チタンコーテッドマイカ、二酸化チタンコーテッドオキシ塩化ビスマス、二酸化チタンコーテッドタルク、着色二酸化チタンコーテッドマイカ、オキシ塩化ビスマス、魚鱗箔等のパール顔料;アルミニウムパウダー、カッパーパウダー等の金属粉末顔料等が挙げられる。
Examples of powder components include talc, kaolin, mica, silk mica (serisite), white mica, gold mica, synthetic mica, red mica, black mica, lithia mica, permiculite, magnesium carbonate, calcium carbonate, aluminum silicate, and kei. Barium acid, calcium silicate, magnesium silicate, strontium silicate, metal tungstate, magnesium, silica, zeolite, barium sulfate, calcined calcium sulfate (baked sekko), calcium phosphate, fluorine apatite, hydroxyapatite, ceramic powder, metal soap (Zinc myristate, calcium palmitate, aluminum stearate, etc.), polyamide resin powder (nylon powder), polyethylene powder, polymethyl methacrylate powder, polystyrene powder, styrene and acrylic acid copolymer resin powder, benzoguanamine resin powder, Organic powders such as polytetrafluoroethylene powder and cellulose powder, silicone powders such as trimethylsilsesquioxane powder, inorganic powders such as boron nitride; inorganic white pigments such as titanium dioxide and zinc oxide; iron oxide (Bengala), Inorganic red pigment such as iron titanate; Inorganic brown pigment such as γ-iron oxide; Inorganic yellow pigment such as yellow iron oxide and ocher; Inorganic black pigment such as black iron oxide, carbon black and low-order titanium dioxide Inorganic purple pigments such as mango violet and baltic violet; inorganic green pigments such as chromium oxide, chromium hydroxide and cobalt titanate; inorganic blue pigments such as ultramarine and dark blue; titanium dioxide coated mica, titanium dioxide coated oxychloride Pearl pigments such as bismuth, titanium dioxide coated talc, colored titanium dioxide coated mica, bismuth oxychloride, fish scale foil; metal powder pigments such as aluminum powder and copper powder can be mentioned.
これら粉末成分を疎水化処理する方法としては、疎水化処理方法としては、撥水性を付与できる方法であればいかなるものでもよく、その方法は問わないが、例えば気相法、液相法、オートクレーブ法、メカノケミカル法等、通常の表面処理方法を用いることができる。疎水化処理剤としては、特に限定されるものではないが、脂肪酸デキストリン処理粉末、トリメチルシロキシ珪酸処理粉末、フッ素変性トリメチルシロキシ珪酸処理粉末、メチルフェニルシロキシ珪酸処理粉末、フッ素変性メチルフェニルシロキシ珪酸処理粉末、ジメチルポリシロキサン、ジフェニルポリシロキサン、メチルフェニルポリシロキサン等の低粘度~高粘度油状ポリシロキサン処理粉末、ガム状ポリシロキサン処理粉末、メチルハイドロジェンポリシロキサン処理粉末、フッ素変性メチルハイドロジェンポリシロキサン処理粉末、メチルトリクロルシラン、メチルトリアルコキシシラン、ヘキサメチルジシラン、ジメチルジクロルシラン、ジメチルジアルコキシシラン、トリメチルクロルシラントリメチルアルコキシシラン等の有機シリル化合物あるいはそれらのフッ素置換体による処理粉末、エチルトリクロルシラン、エチルトリアルコキシシラン、プロピルトリクロルシラン、プロピルトリアルコキシシラン、ヘキシルトリクロルシラン、ヘキシルトリアルコキシシラン、長鎖アルキルトリクロルシラン、長鎖アルキルトリエトキシシラン等の有機変性シランあるいはそれらのフッ素置換体による処理粉末、アミノ変性ポリシロキサン処理粉末、フッ素変性ポリシロキサン処理粉末、フッ化アルキルリン酸処理粉末等が挙げられる。
The method for hydrophobizing these powder components may be any method as long as it can impart water repellency, and the method is not limited, but for example, a vapor phase method, a liquid phase method, or an autoclave. A normal surface treatment method such as a method or a mechanochemical method can be used. The hydrophobic treatment agent is not particularly limited, but is not particularly limited, but is a fatty acid dextrin-treated powder, a trimethylsiloxysilicate-treated powder, a fluorine-modified trimethylsiloxysilicate-treated powder, a methylphenylsiloxysilicate-treated powder, and a fluorine-modified methylphenylsiloxysilicate-treated powder. , Dimethylpolysiloxane, diphenylpolysiloxane, methylphenylpolysiloxane and other low-viscosity to high-viscosity oily polysiloxane-treated powders, gum-like polysiloxane-treated powders, methylhydrogenpolysiloxane-treated powders, fluorine-modified methylhydrogenpolysiloxane-treated powders. , Methyltricrolsilane, Methyltrialkoxysilane, Hexamethyldisilane, dimethyldichlorosilane, dimethyldialkoxysilane, trimethylchlorsilane, Organic silyl compounds such as trimethylalkoxysilane, or powders treated with their fluorine-substituted powders, ethyltricrolsilane, ethyl. Organically modified silanes such as trialkoxysilanes, propyltrichlorosilanes, propyltrialkoxysilanes, hexyltrichlorosilanes, hexyltrialkoxysilanes, long-chain alkyltrichlorosilanes, long-chain alkyltriethoxysilanes, or powders treated with their fluorine substituents, amino. Examples thereof include modified polysiloxane-treated powder, fluorine-modified polysiloxane-treated powder, and fluorinated alkylphosphate-treated powder.
本発明のシート状化粧料の基剤に配合される油性成分は、通常化粧料に配合され得る油性成分であれば特に限定されるものでなく、例えば、油脂、ロウ類、炭化水素油、高級アルコール、合成エステル油、シリコーン油等が挙げられる。
The oily component to be blended in the base of the sheet-shaped cosmetic of the present invention is not particularly limited as long as it is an oily component that can be usually blended in cosmetics. Examples include alcohol, synthetic ester oil, silicone oil and the like.
油脂としては、アボガド油、ツバキ油、月見草油、タートル油、マカデミアナッツ油、トウモロコシ油、ミンク油、オリーブ油、ナタネ油、卵黄油、ゴマ油、パーシック油、小麦胚芽油、サザンカ油、ヒマシ油、アマニ油、サフラワー油、綿実油、エノ油、大豆油、落花生油、茶実油、カヤ油、コメヌカ油、シナギリ油、日本キリ油、ホホバ油、胚芽油、トリグリセリン、トリオクタン酸グリセリン、トリイソパルミチン酸グリセリン等の液体油脂;カカオ脂、ヤシ油、馬脂、硬化ヤシ油、パーム油、牛脂、羊脂、硬化牛脂、パーム核油、豚脂、牛骨脂、モクロウ核油、硬化油、牛脚脂、モクロウ、硬化ヒマシ油等の固体油脂などが例示される。
Oils include avocado oil, camellia oil, evening primrose oil, turtle oil, macadamia nut oil, corn oil, mink oil, olive oil, rapeseed oil, egg yolk oil, sesame oil, persic oil, wheat germ oil, southern ka oil, castor oil, and flaxseed oil. , Saflower oil, cottonseed oil, eno oil, soybean oil, peanut oil, teaseed oil, kaya oil, rice bran oil, cinnamon oil, Japanese millet oil, jojoba oil, germ oil, triglycerin, glycerin trioctanoate, triisopalmitic acid Liquid fats and oils such as glycerin; cacao butter, palm oil, horse fat, hardened palm oil, palm oil, beef fat, sheep fat, hardened beef fat, palm kernel oil, pork fat, beef bone fat, mokuro kernel oil, hardened oil, beef leg Examples thereof include solid fats and oils such as fats, mokurou, and hardened castor oil.
ロウ類としては、ミツロウ、カンデリラロウ、綿ロウ、カルナウバロウ、ベイベリーロウ、イボタロウ、鯨ロウ、モンタンロウ、ヌカロウ、ラノリン、カポックロウ、酢酸ラノリン、液状ラノリン、サトウキビロウ、ラノリン脂肪酸イソプロピル、ラウリン酸ヘキシル、還元ラノリン、ジョジョバロウ、硬質ラノリン、セラックロウ、POEラノリンアルコールエーテル、POEラノリンアルコールアセテート、POEコレステロールエーテル、ラノリン脂肪酸ポリエチレングリコール、POE水素添加ラノリンアルコールエーテルなどが例示される。
Examples of waxes include honey wax, candelilla wax, cotton wax, carnauba wax, bayberry wax, ibotarou, whale wax, monttan wax, nukarou, lanolin, capoc wax, lanolin acetate, liquid lanolin, sugar cane, lanolin fatty acid isopropyl, hexyl laurate, reduced lanolin, and jojo. Examples thereof include barrow, hard lanolin, serrac wax, POE lanolin alcohol ether, POE lanolin alcohol acetate, POE cholesterol ether, lanolin fatty acid polyethylene glycol, POE hydrogenated lanolin alcohol ether and the like.
炭化水素油としては、流動パラフィン、オゾケライト、スクワレン、プリスタン、パラフィン、セレシン、スクワレン、ワセリン、マイクロクリスタリンワックスなどが例示される。
Examples of the hydrocarbon oil include liquid paraffin, zokerite, squalene, pristane, paraffin, selecin, squalene, petrolatum, and microcrystalline wax.
高級アルコールとしては、ラウリルアルコール、セチルアルコール、ステアリルアルコール、ベヘニルアルコール、ミリスチルアルコール、オレイルアルコール、セトステアリルアルコール等の直鎖アルコール;モノステアリルグリセリンエーテル(バチルアルコール)、2-デシルテトラデシノール、ラノリンアルコール、コレステロール、フィトステロール、ヘキシルドデカノール、イソステアリルアルコール、オクチルドデカノール等の分岐鎖アルコールなどが例示される。
Higher alcohols include linear alcohols such as lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, myristyl alcohol, oleyl alcohol, and cetostearyl alcohol; monostearyl glycerin ether (bacyl alcohol), 2-decyltetradecinol, and lanolin alcohol. Examples thereof include branched chain alcohols such as cholesterol, phytosterol, hexyldodecanol, isostearyl alcohol, and octyldodecanol.
合成エステル油としては、ミリスチン酸イソプロピル、オクタン酸セチル、ミリスチン酸オクチルドデシル、パルミチン酸イソプロピル、ステアリン酸ブチル、ラウリン酸ヘキシル、ミリスチン酸ミリスチル、オレイン酸デシル、ジメチルオクタン酸ヘキシルデシル、乳酸セチル、乳酸ミリスチル、酢酸ラノリン、ステアリン酸イソセチル、イソステアリン酸イソセチル、12-ヒドロキシステアリル酸コレステリル、ジ-2-エチルヘキシル酸エチレングリコール、ジペンタエリスリトール脂肪酸エステル、モノイソステアリン酸N-アルキルグリコール、ジカプリン酸ネオペンチルグリコール、リンゴ酸ジイソステアリル、ジ-2-ヘプチルウンデカン酸グリセリン、トリ-2-エチルヘキシル酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラ-2-エチルヘキシル酸ペンタンエリスリトール、トリー2-エチルヘキシル酸グリセリン、トリイソステアリン酸トリメチロールプロパン、セチル2-エチルヘキサノエート、2-エチルヘキシルパルミテート、トリミリスチン酸グリセリン、トリ-2-ヘプチルウンデカン酸グリセライド、ヒマシ油脂肪酸メチルエステル、オレイン酸オイル、アセトグリセライド、パルミチン酸2-ヘプチルウンデシル、アジピン酸ジイソブチル、N-ラウロイル-L-グルタミン酸-2-クチルドデシルエステル、アジピン酸ジ-2-ヘプチルウンデシル、エチルラウレート、セバチン酸ジ-2-エチルヘキシル、ミリスチン酸2-ヘキシルデシル、パルミチン酸2-ヘキシルデシル、アジピン酸2-ヘキシルデシル、セバチン酸ジイソプロピル、コハク酸2-エチルヘキシル、酢酸エチル、酢酸ブチル、酢酸アミル、クエン酸トリエチル、クロタミトン(C13H17NO)などが例示される。
Synthetic ester oils include isopropyl myristate, cetyl octanate, octyldodecyl myristate, isopropyl palmitate, butyl stearate, hexyl laurate, myristyl myristate, decyl oleate, hexyldecyl dimethyloctanoate, cetyl lactate, myristyl lactate. , Lanorin acetate, Isocetyl stearate, Isocetyl isostearate, Cholesteryl 12-hydroxystearyl, Di-2-ethylhexylateethylene glycol, Dipentaerythritol fatty acid ester, N-alkylglycol monoisostearate, Neopentyl glycol dicaprate, Appleic acid Diisostearyl, glycerin di-2-heptylundecanoate, trimethylolpropane tri-2-ethylhexylate, trimethylolpropane triisostearate, pentane erythritol tetra-2-ethylhexylate, glycerin tri-2-ethylhexylate, triisostearate Methylol propane, cetyl 2-ethylhexanoate, 2-ethylhexyl palmitate, glycerin trimyristate, tri-2-heptylundecanoic acid glyceride, castor oil fatty acid methyl ester, oleic acid oil, acetoglyceride, palmitate 2-heptylun Decyl, diisobutyl adipate, N-lauroyl-L-glutamate-2-cutyldodecyl ester, di-2-heptylundecyl adipate, ethyllaurate, di-2-ethylhexyl sebatate, 2-hexyldecyl myristate, palmitin Examples thereof include 2-hexyl decyl acid, 2-hexyl decyl adipate, diisopropyl sebatate, 2-ethylhexyl succinate, ethyl acetate, butyl acetate, amyl acetate, triethyl citrate, and crotamiton (C 13 H 17 NO).
シリコーン油としては、(F)以外のジメチルポリシロキサン、メチルフェニルポリシロキサン、メチルハイドロジェンポリシロキサン等の鎖状ポリシロキサン;デカメチルポリシロキサン、ドデカメチルポリシロキサン、テトラメチルテトラハイドロジェンポリシロキサン等の環状ポリシロキサン;3次元網目構造を形成しているシリコ-ン樹脂、シリコーンゴムなどが例示される。
Examples of the silicone oil include chain polysiloxanes other than (F) such as dimethylpolysiloxane, methylphenylpolysiloxane, and methylhydrogenpolysiloxane; decamethylpolysiloxane, dodecamethylpolysiloxane, tetramethyltetrahydrogenpolysiloxane, and the like. Cyclic polysiloxane; silicone resin, silicone rubber, etc. forming a three-dimensional network structure are exemplified.
乳化剤としては、グリセリンまたはポリグリセリン脂肪酸エステル類、プロピレングリコール脂肪酸エステル類、POEソルビタン脂肪酸エステル類、POEソルビット脂肪酸エステル類、POE脂肪酸エステル類、POEアルキルエーテル類、POEアルキルフェニルエーテル類、POE・POPアルキルエーテル類、POE蜜ロウ・ラノリン誘導体、アルカノールアミド類、POEプロピレングリコール脂肪酸エステル類、POEアルキルアミン、POE脂肪酸アミド類から選択される1種または2種以上を配合する。
Examples of the emulsifier include glycerin or polyglycerin fatty acid esters, propylene glycol fatty acid esters, POE sorbitan fatty acid esters, POE sorbit fatty acid esters, POE fatty acid esters, POE alkyl ethers, POE alkyl phenyl ethers, and POE / POP alkyl. One or more selected from ethers, POE beeswax / lanolin derivatives, alkanolamides, POEpropylene glycol fatty acid esters, POE alkylamines, and POE fatty acid amides are blended.
上記例示した成分以外のその他の配合可能成分としては、例えば、防腐剤(エチルパラベン、ブチルパラベン等);消炎剤(例えば、グリチルリチン酸誘導体、グリチルレチン酸誘導体、サリチル酸誘導体、ヒノキチオール、酸化亜鉛、アラントイン等);(B)以外の美白剤(例えば、ユキノシタ抽出物、アルブチン等);各種抽出物(例えば、オウバク、オウレン、シコン、シャクヤク、センブリ、バーチ、セージ、ビワ、ニンジン、アロエ、ゼニアオイ、アイリス、ブドウ、ヨクイニン、ヘチマ、ユリ、サフラン、センキュウ、ショウキュウ、オトギリソウ、オノニス、ニンニク、トウガラシ、チンピ、トウキ、海藻等)、賦活剤(例えば、ローヤルゼリー、感光素、コレステロール誘導体等);血行促進剤(例えば、ノニル酸ワレニルアミド、ニコチン酸ベンジルエステル、ニコチン酸β-ブトキシエチルエステル、カプサイシン、ジンゲロン、カンタリスチンキ、イクタモール、タンニン酸、α-ボルネオール、ニコチン酸トコフェロール、イノシトールヘキサニコチネート、シクランデレート、シンナリジン、トラゾリン、アセチルコリン、ベラパミル、セファランチン、γ-オリザノール等);酸化防止剤(酢酸トコフェロール等);抗脂漏剤(例えば、硫黄、チアントール等);抗炎症剤(例えば、トラネキサム酸、チオタウリン、ヒポタウリン等);紫外線吸収剤等が挙げられる。ただしこれら例示に限定されるものでない。
Examples of other compoundable components other than the above-exemplified components include preservatives (ethylparaben, butylparaben, etc.); anti-inflammatory agents (eg, glycyrrhizinic acid derivative, glycyrrhetinic acid derivative, salicylic acid derivative, hinokithiol, zinc oxide, allantin, etc.). ); Whitening agents other than (B) (eg, Yukinoshita extract, Arbutin, etc.); Various extracts (eg, Oubaku, Ouren, Shikon, Shakuyaku, Senburi, Birch, Sage, Biwa, Carrot, Aloe, Zeniaoi, Iris, etc. Grape, Yokuinin, Hechima, Yuri, Saffron, Senkyu, Shokyu, Otogirisou, Ononis, Garlic, Togarashi, Chimpi, Touki, Seaweed, etc.), Activators (eg, Royal Jelly, Photosensitizer, Cholesterol Derivatives, etc.); For example, nonylic acid valenylamide, nicotinic acid benzyl ester, nicotinic acid β-butoxyethyl ester, capsaicin, zingeron, cantalistinki, ictamol, tannic acid, α-borneol, tocopherol nicotinate, inositol hexanicotinate, cyclandelate, cinnaridine. , Trazoline, acetylcholine, verapamil, cepharanthin, γ-orizanol, etc.); Antioxidants (tocopherol acetate, etc.); Antifat leak agents (eg, sulfur, thiantol, etc.); Anti-inflammatory agents (eg, tranexamic acid, thiotaurine, hypotaurine, etc.) ); Examples include an ultraviolet absorber. However, it is not limited to these examples.
以下に実施例を挙げて本発明をさらに具体的に説明するが、本発明はこれによってなんら限定されるものではない。配合量は特記しない限りすべて質量%である。
The present invention will be described in more detail with reference to examples below, but the present invention is not limited thereto. Unless otherwise specified, all blending amounts are mass%.
(実施例および比較例)
下記表1~3に示す処方で基剤を作製し、作製した基剤について静置粘度および動粘度を以下の条件で測定した。また、基剤を不織布(コットン、パルプ、ポリエチレンテレフタレートからなる混合繊維、目付け70g/m2、含浸量14.5倍)に含浸させてシート状化粧料を作製し、使用性について以下の基準で評価した。 (Examples and comparative examples)
Bases were prepared according to the formulations shown in Tables 1 to 3 below, and the static viscosity and kinematic viscosity of the prepared bases were measured under the following conditions. In addition, the base is impregnated into a non-woven fabric (mixed fiber made of cotton, pulp, polyethylene terephthalate, basis weight 70 g / m 2 , impregnation amount 14.5 times) to prepare a sheet-shaped cosmetic, and the usability is based on the following criteria. evaluated.
下記表1~3に示す処方で基剤を作製し、作製した基剤について静置粘度および動粘度を以下の条件で測定した。また、基剤を不織布(コットン、パルプ、ポリエチレンテレフタレートからなる混合繊維、目付け70g/m2、含浸量14.5倍)に含浸させてシート状化粧料を作製し、使用性について以下の基準で評価した。 (Examples and comparative examples)
Bases were prepared according to the formulations shown in Tables 1 to 3 below, and the static viscosity and kinematic viscosity of the prepared bases were measured under the following conditions. In addition, the base is impregnated into a non-woven fabric (mixed fiber made of cotton, pulp, polyethylene terephthalate, basis weight 70 g / m 2 , impregnation amount 14.5 times) to prepare a sheet-shaped cosmetic, and the usability is based on the following criteria. evaluated.
(静置粘度)
作製した基剤について、レオメーターとしてMCR300(Anton―Paar社製)を用い、25℃雰囲気下において、せん断速度0.05[1/s]時の粘度を測定した。 (Standing viscosity)
The prepared base was measured for viscosity at a shear rate of 0.05 [1 / s] in an atmosphere of 25 ° C. using MCR300 (manufactured by Antonio-Paar) as a leometer.
作製した基剤について、レオメーターとしてMCR300(Anton―Paar社製)を用い、25℃雰囲気下において、せん断速度0.05[1/s]時の粘度を測定した。 (Standing viscosity)
The prepared base was measured for viscosity at a shear rate of 0.05 [1 / s] in an atmosphere of 25 ° C. using MCR300 (manufactured by Antonio-Paar) as a leometer.
(動粘度)
作製した基剤についてVISCOMETER TVB-15(東機産業社製)、ローターNo.2、No.3、No.4を用い、回転数12rpm、1分間の条件で測定した。 (Dynamic viscosity)
About the prepared base VISCOMETER TVB-15 (manufactured by Toki Sangyo Co., Ltd.), Rotor No. 2. No. 3, No. No. 4 was used, and the measurement was performed under the conditions of a rotation speed of 12 rpm and 1 minute.
作製した基剤についてVISCOMETER TVB-15(東機産業社製)、ローターNo.2、No.3、No.4を用い、回転数12rpm、1分間の条件で測定した。 (Dynamic viscosity)
About the prepared base VISCOMETER TVB-15 (manufactured by Toki Sangyo Co., Ltd.), Rotor No. 2. No. 3, No. No. 4 was used, and the measurement was performed under the conditions of a rotation speed of 12 rpm and 1 minute.
(シートを貼付するときの液だれのなさ)
作製したシート状化粧料を専門パネラー10名に使用してもらい、シートを貼付するときの液だれのなさについて評価した。評価基準は以下の通りである。
<評価点>
5点:非常に良好
4点:良好
3点:普通
2点:不良
1点:非常に不良
<評価基準>
A+:平均点が4.5点以上
A :平均点が3.5点以上4.5点未満
B :平均点が2.5点以上3.5点未満
C :平均点が2.5点未満 (No dripping when attaching the sheet)
The prepared sheet-shaped cosmetics were used by 10 specialized panelists, and the lack of dripping when the sheets were applied was evaluated. The evaluation criteria are as follows.
<Evaluation points>
5 points: Very good 4 points: Good 3 points: Normal 2 points: Defective 1 point: Very poor <Evaluation criteria>
A +: Average score is 4.5 points or more A: Average score is 3.5 points or more and less than 4.5 points B: Average score is 2.5 points or more and less than 3.5 points C: Average score is less than 2.5 points
作製したシート状化粧料を専門パネラー10名に使用してもらい、シートを貼付するときの液だれのなさについて評価した。評価基準は以下の通りである。
<評価点>
5点:非常に良好
4点:良好
3点:普通
2点:不良
1点:非常に不良
<評価基準>
A+:平均点が4.5点以上
A :平均点が3.5点以上4.5点未満
B :平均点が2.5点以上3.5点未満
C :平均点が2.5点未満 (No dripping when attaching the sheet)
The prepared sheet-shaped cosmetics were used by 10 specialized panelists, and the lack of dripping when the sheets were applied was evaluated. The evaluation criteria are as follows.
<Evaluation points>
5 points: Very good 4 points: Good 3 points: Normal 2 points: Defective 1 point: Very poor <Evaluation criteria>
A +: Average score is 4.5 points or more A: Average score is 3.5 points or more and less than 4.5 points B: Average score is 2.5 points or more and less than 3.5 points C: Average score is less than 2.5 points
(シートの密着感)
作製したシート状化粧料を10分間専門パネラー10名に使用してもらい、シートの密着感について評価した。評価基準は以下の通りである。
<評価点>
5点:非常に良好
4点:良好
3点:普通
2点:不良
1点:非常に不良
<評価基準>
A+:平均点が4.5点以上
A :平均点が3.5点以上4.5点未満
B :平均点が2.5点以上3.5点未満
C :平均点が2.5点未満 (Sheet adhesion)
The prepared sheet-shaped cosmetics were used by 10 specialized panelists for 10 minutes, and the adhesion of the sheets was evaluated. The evaluation criteria are as follows.
<Evaluation points>
5 points: Very good 4 points: Good 3 points: Normal 2 points: Defective 1 point: Very poor <Evaluation criteria>
A +: Average score is 4.5 points or more A: Average score is 3.5 points or more and less than 4.5 points B: Average score is 2.5 points or more and less than 3.5 points C: Average score is less than 2.5 points
作製したシート状化粧料を10分間専門パネラー10名に使用してもらい、シートの密着感について評価した。評価基準は以下の通りである。
<評価点>
5点:非常に良好
4点:良好
3点:普通
2点:不良
1点:非常に不良
<評価基準>
A+:平均点が4.5点以上
A :平均点が3.5点以上4.5点未満
B :平均点が2.5点以上3.5点未満
C :平均点が2.5点未満 (Sheet adhesion)
The prepared sheet-shaped cosmetics were used by 10 specialized panelists for 10 minutes, and the adhesion of the sheets was evaluated. The evaluation criteria are as follows.
<Evaluation points>
5 points: Very good 4 points: Good 3 points: Normal 2 points: Defective 1 point: Very poor <Evaluation criteria>
A +: Average score is 4.5 points or more A: Average score is 3.5 points or more and less than 4.5 points B: Average score is 2.5 points or more and less than 3.5 points C: Average score is less than 2.5 points
(シートをはがした後のもちもち感)
作製したシート状化粧料を10分間専門パネラー10名に使用してもらい、シートをはがした後のもちもち感について評価した。評価基準は以下の通りである。
<評価点>
5点:非常に良好
4点:良好
3点:普通
2点:不良
1点:非常に不良
<評価基準>
A+:平均点が4.5点以上
A :平均点が3.5点以上4.5点未満
B :平均点が2.5点以上3.5点未満
C :平均点が2.5点未満 (Feeling of stickiness after peeling off the sheet)
The prepared sheet-shaped cosmetics were used by 10 specialized panelists for 10 minutes, and the feeling of stickiness after the sheet was peeled off was evaluated. The evaluation criteria are as follows.
<Evaluation points>
5 points: Very good 4 points: Good 3 points: Normal 2 points: Defective 1 point: Very poor <Evaluation criteria>
A +: Average score is 4.5 points or more A: Average score is 3.5 points or more and less than 4.5 points B: Average score is 2.5 points or more and less than 3.5 points C: Average score is less than 2.5 points
作製したシート状化粧料を10分間専門パネラー10名に使用してもらい、シートをはがした後のもちもち感について評価した。評価基準は以下の通りである。
<評価点>
5点:非常に良好
4点:良好
3点:普通
2点:不良
1点:非常に不良
<評価基準>
A+:平均点が4.5点以上
A :平均点が3.5点以上4.5点未満
B :平均点が2.5点以上3.5点未満
C :平均点が2.5点未満 (Feeling of stickiness after peeling off the sheet)
The prepared sheet-shaped cosmetics were used by 10 specialized panelists for 10 minutes, and the feeling of stickiness after the sheet was peeled off was evaluated. The evaluation criteria are as follows.
<Evaluation points>
5 points: Very good 4 points: Good 3 points: Normal 2 points: Defective 1 point: Very poor <Evaluation criteria>
A +: Average score is 4.5 points or more A: Average score is 3.5 points or more and less than 4.5 points B: Average score is 2.5 points or more and less than 3.5 points C: Average score is less than 2.5 points
(シートをはがした後のべたつきのなさ)
作製したシート状化粧料を10分間専門パネラー10名に使用してもらい、シートをはがした後のべたつきのなさについて評価した。評価基準は以下の通りである。
<評価点>
5点:非常に良好
4点:良好
3点:普通
2点:不良
1点:非常に不良
<評価基準>
A+:平均点が4.5点以上
A :平均点が3.5点以上4.5点未満
B :平均点が2.5点以上3.5点未満
C :平均点が2.5点未満 (No stickiness after peeling off the sheet)
The prepared sheet-shaped cosmetics were used by 10 specialized panelists for 10 minutes, and the non-stickiness after peeling off the sheet was evaluated. The evaluation criteria are as follows.
<Evaluation points>
5 points: Very good 4 points: Good 3 points: Normal 2 points: Defective 1 point: Very poor <Evaluation criteria>
A +: Average score is 4.5 points or more A: Average score is 3.5 points or more and less than 4.5 points B: Average score is 2.5 points or more and less than 3.5 points C: Average score is less than 2.5 points
作製したシート状化粧料を10分間専門パネラー10名に使用してもらい、シートをはがした後のべたつきのなさについて評価した。評価基準は以下の通りである。
<評価点>
5点:非常に良好
4点:良好
3点:普通
2点:不良
1点:非常に不良
<評価基準>
A+:平均点が4.5点以上
A :平均点が3.5点以上4.5点未満
B :平均点が2.5点以上3.5点未満
C :平均点が2.5点未満 (No stickiness after peeling off the sheet)
The prepared sheet-shaped cosmetics were used by 10 specialized panelists for 10 minutes, and the non-stickiness after peeling off the sheet was evaluated. The evaluation criteria are as follows.
<Evaluation points>
5 points: Very good 4 points: Good 3 points: Normal 2 points: Defective 1 point: Very poor <Evaluation criteria>
A +: Average score is 4.5 points or more A: Average score is 3.5 points or more and less than 4.5 points B: Average score is 2.5 points or more and less than 3.5 points C: Average score is less than 2.5 points
処方および評価結果を表1~3に示す。なお、表に示す成分のうち、主だったものの市販品名を以下に示す。
・(PEG-240/デシルテトラデセス-20/HDI)コポリマー:アデカノールGT-700(株式会社ADEKA製)純分99.95質量%
・カルボマー:カーボポール980(日光ケミカルズ株社製)
・イソステアリン酸PEG-20グリセリル:エマレックスGWIS-120(日本エマルジョン株社製)
・PEG-60水添ヒマシ油:ニッコールHCO-60(日光ケミカルズ株社製)
・ジメチコン*1:シリコーンKF-96A-6T(信越シリコーン社製)
・ジメチコン*2:メチルポリシロキサン100CS(25℃における動粘度100mm2/s)
・イソステアリン酸:イソステアリン酸SX(高級アルコール工業社製) The prescription and evaluation results are shown in Tables 1 to 3. Of the components shown in the table, the names of the main commercial products are shown below.
(PEG-240 / decyltetradeceth-20 / HDI) copolymer: Adecanol GT-700 (manufactured by ADEKA Corporation) Pure content 99.95% by mass
・ Carbo-mer: Carbo-mer 980 (manufactured by Nikko Chemicals Co., Ltd.)
-PEG-20 glyceryl isostearate: Emarex GWIS-120 (manufactured by Nippon Emulsion Co., Ltd.)
-PEG-60 hydrogenated castor oil: Nikkor HCO-60 (manufactured by Nikko Chemicals Co., Ltd.)
・ Dimethicone * 1: Silicone KF-96A-6T (manufactured by Shinetsu Silicone Co., Ltd.)
Dimethicone * 2: Methylpolysiloxane 100CS (kinematic viscosity at 25 ° C. 100 mm 2 / s)
-Isostearic acid: Isostearic acid SX (manufactured by Higher Alcohol Industry Co., Ltd.)
・(PEG-240/デシルテトラデセス-20/HDI)コポリマー:アデカノールGT-700(株式会社ADEKA製)純分99.95質量%
・カルボマー:カーボポール980(日光ケミカルズ株社製)
・イソステアリン酸PEG-20グリセリル:エマレックスGWIS-120(日本エマルジョン株社製)
・PEG-60水添ヒマシ油:ニッコールHCO-60(日光ケミカルズ株社製)
・ジメチコン*1:シリコーンKF-96A-6T(信越シリコーン社製)
・ジメチコン*2:メチルポリシロキサン100CS(25℃における動粘度100mm2/s)
・イソステアリン酸:イソステアリン酸SX(高級アルコール工業社製) The prescription and evaluation results are shown in Tables 1 to 3. Of the components shown in the table, the names of the main commercial products are shown below.
(PEG-240 / decyltetradeceth-20 / HDI) copolymer: Adecanol GT-700 (manufactured by ADEKA Corporation) Pure content 99.95% by mass
・ Carbo-mer: Carbo-mer 980 (manufactured by Nikko Chemicals Co., Ltd.)
-PEG-20 glyceryl isostearate: Emarex GWIS-120 (manufactured by Nippon Emulsion Co., Ltd.)
-PEG-60 hydrogenated castor oil: Nikkor HCO-60 (manufactured by Nikko Chemicals Co., Ltd.)
・ Dimethicone * 1: Silicone KF-96A-6T (manufactured by Shinetsu Silicone Co., Ltd.)
Dimethicone * 2: Methylpolysiloxane 100CS (kinematic viscosity at 25 ° C. 100 mm 2 / s)
-Isostearic acid: Isostearic acid SX (manufactured by Higher Alcohol Industry Co., Ltd.)
表1に示す実施例1および2のシート状化粧料は、肌に貼付しても液だれがなく、シートの密着性がよく、シートを剥がした後のもちもち感に優れていた。一方、(A)疎水変性ポリエーテルウレタンを含まない比較例1や2のシート状化粧料は、肌に貼付した際に液だれが顕著で、密着性や、シートを剥がした後のもちもち感も得られなかった。実施例3および4は塩型美白薬剤としてアスコルビン酸グルコシドを配合したものであるが、実施例1や2と同様に肌に貼付しても液だれがなく、シートの密着性がよく、シートを剥がした後のもちもち感に優れていた。一方、(A)疎水変性ポリエーテルウレタンを含まない比較例3のシート状化粧料は、肌に貼付した際に液だれが顕著で、密着性や、シートを剥がした後のもちもち感も得られなかった。
The sheet-shaped cosmetics of Examples 1 and 2 shown in Table 1 did not drip even when applied to the skin, had good adhesion to the sheet, and had an excellent stickiness after the sheet was peeled off. On the other hand, (A) the sheet-shaped cosmetics of Comparative Examples 1 and 2 containing no hydrophobically modified polyether urethane have remarkable dripping when applied to the skin, and also have adhesiveness and a sticky feeling after the sheet is peeled off. I couldn't get it. Examples 3 and 4 contain ascorbic acid glucoside as a salt-type whitening agent, but as in Examples 1 and 2, there is no dripping even when applied to the skin, the sheet adheres well, and the sheet is used. It had an excellent feeling of stickiness after being peeled off. On the other hand, (A) the sheet-like cosmetic of Comparative Example 3 containing no hydrophobically modified polyether urethane has remarkable dripping when applied to the skin, and also provides adhesion and a sticky feeling after the sheet is peeled off. I didn't.
表2に示す実施例5~8は実施例1の処方においてさらにイソステアリン酸を追加した例、実施例9および10は(A)疎水変性ポリエーテルウレタンを減量した例であるが、いずれも肌に貼付しても液だれがなく、シートを剥がした後のもちもち感に優れ、シートの密着性が高いにもかかわらず剥がした後にべたつきがなかった。また、静置粘度が高いわりに動粘度が低いので、シートを剥がした後に肌がぬるつかないものとすることができた。
Examples 5 to 8 shown in Table 2 are examples in which isostearic acid is further added in the formulation of Example 1, and Examples 9 and 10 are examples in which the amount of (A) hydrophobically modified polyether urethane is reduced. There was no dripping even after sticking, and the stickiness after peeling off the sheet was excellent, and despite the high adhesion of the sheet, there was no stickiness after peeling off. Moreover, since the kinematic viscosity is low in spite of the high static viscosity, it was possible to prevent the skin from becoming slimy after the sheet was peeled off.
表3に示す実施例11は活性剤を減量した例、実施例12および13はポリオキシエチレン硬化ヒマシ油を追加した例、実施例14は動粘度が50mm2/s以上のジメチコンを追加した例、実施例15はジグリセリンを追加した例、実施例16はジプロピレングリコールを追加した例であるが、これらも肌に貼付しても液だれがなく、シートを剥がした後のもちもち感に優れ、シートの密着性が高いにもかかわらず剥がした後にべたつきがなかった。
Example 11 shown in Table 3 is an example in which the amount of the activator is reduced, Examples 12 and 13 are examples in which polyoxyethylene hydrogenated castor oil is added, and Example 14 is an example in which dimethicone having a kinematic viscosity of 50 mm 2 / s or more is added. Example 15 is an example in which diglycerin is added, and Example 16 is an example in which dipropylene glycol is added. However, even if these are also applied to the skin, there is no dripping, and the feeling of stickiness after peeling off the sheet is excellent. Although the sheet had high adhesion, it was not sticky after being peeled off.
Claims (12)
- 少なくとも、
(A)疎水変性ポリエーテルウレタンと、
(B)塩型美白薬剤と、
を含む基剤を、不織布に含浸させてなるシート状化粧料。 at least,
(A) Hydrophobic-modified polyether urethane and
(B) Salt-type whitening agent and
A sheet-like cosmetic product obtained by impregnating a non-woven fabric with a base containing. - 前記(B)塩型美白薬剤が4-メトキシサリチル酸カリウム塩またはアスコルビン酸グルコシドである請求項1記載のシート状化粧料。 The sheet-shaped cosmetic according to claim 1, wherein the (B) salt-type whitening agent is 4-methoxysalicylic acid potassium salt or ascorbic acid glucoside.
- 前記(B)塩型美白薬剤に対する前記(A)疎水変性ポリエーテルウレタンの質量比が0.2~1である請求項1または2記載のシート状化粧料。 The sheet-shaped cosmetic according to claim 1 or 2, wherein the mass ratio of the (A) hydrophobically modified polyether urethane to the (B) salt-type whitening agent is 0.2 to 1.
- さらに(C)カルボキシビニルポリマーを含む請求項1、2または3記載のシート状化粧料。 The sheet-shaped cosmetic according to claim 1, 2 or 3, further comprising (C) a carboxyvinyl polymer.
- さらに(D)ポリオキシエチレン脂肪酸グリセリルまたはポリオキシエチレン硬化ヒマシ油の少なくともいずれかを含む請求項1~4いずれか1項記載のシート状化粧料。 The sheet-shaped cosmetic according to any one of claims 1 to 4, further comprising (D) at least one of polyoxyethylene fatty acid glyceryl or polyoxyethylene hydrogenated castor oil.
- さらに(E)イソステアリン酸を含む請求項1~5いずれか1項記載のシート状化粧料。 The sheet-shaped cosmetic according to any one of claims 1 to 5, further comprising (E) isostearic acid.
- 前記(A)疎水変性ポリエーテルウレタンが(PEG-240/デシルテトラデセス-20/HDI)コポリマーである請求項1~6いずれか1項記載のシート状化粧料。 The sheet-like cosmetic according to any one of claims 1 to 6, wherein the (A) hydrophobically modified polyether urethane is a (PEG-240 / decyltetradeceth-20 / HDI) copolymer.
- 前記(D)ポリオキシエチレン脂肪酸グリセリルが(モノ)イソステアリン酸PEG-20グリセリルである請求項1~7いずれか1項記載のシート状化粧料。 The sheet-shaped cosmetic according to any one of claims 1 to 7, wherein the (D) polyoxyethylene fatty acid glyceryl is (mono) PEG-20 glyceryl isostearate.
- 前記(D)ポリオキシエチレン硬化ヒマシ油がPEG60水添ヒマシ油である請求項1~7いずれか1項記載のシート状化粧料。 The sheet-shaped cosmetic according to any one of claims 1 to 7, wherein the (D) polyoxyethylene hydrogenated castor oil is PEG60 hydrogenated castor oil.
- さらに(F)ジグリセリンを基剤全量に対し0.2~4質量%含む請求項1~9いずれか1項記載のシート状化粧料。 The sheet-shaped cosmetic according to any one of claims 1 to 9, further comprising (F) diglycerin in an amount of 0.2 to 4% by mass based on the total amount of the base.
- さらに(G)25℃における動粘度が50mm2/s以上のジメチコンを基剤全量に対し2~5質量%含む請求項1~10いずれか1項記載のシート状化粧料。 (G) The sheet-shaped cosmetic according to any one of claims 1 to 10, further comprising dimethicone having a kinematic viscosity of 50 mm 2 / s or more at 25 ° C. in an amount of 2 to 5% by mass based on the total amount of the base.
- 前記不織布が、ポリエステル系繊維およびセルロース系繊維を含むものである請求項1~11いずれか1項記載のシート状化粧料。 The sheet-shaped cosmetic according to any one of claims 1 to 11, wherein the nonwoven fabric contains polyester fibers and cellulosic fibers.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202180075329.2A CN116782866A (en) | 2020-12-08 | 2021-12-02 | Sheet-like cosmetic |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020203340A JP2022090804A (en) | 2020-12-08 | 2020-12-08 | Sheet-like cosmetic |
JP2020-203340 | 2020-12-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022124201A1 true WO2022124201A1 (en) | 2022-06-16 |
Family
ID=81974449
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2021/044343 WO2022124201A1 (en) | 2020-12-08 | 2021-12-02 | Sheet-like cosmetic |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP2022090804A (en) |
CN (1) | CN116782866A (en) |
WO (1) | WO2022124201A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117752557A (en) * | 2024-02-22 | 2024-03-26 | 广州旭妆生物科技有限公司 | temperature-sensitive facial mask with anti-aging and cleaning functions and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013121922A (en) * | 2011-12-09 | 2013-06-20 | Lion Corp | Sheet-like cosmetic |
JP2020105077A (en) * | 2018-12-26 | 2020-07-09 | クラシエホームプロダクツ株式会社 | Emulsion cosmetic |
JP2020132631A (en) * | 2019-02-15 | 2020-08-31 | ロート製薬株式会社 | External skin composition |
JP2020193154A (en) * | 2019-05-24 | 2020-12-03 | 株式会社マンダム | Sheet cosmetics |
-
2020
- 2020-12-08 JP JP2020203340A patent/JP2022090804A/en active Pending
-
2021
- 2021-12-02 CN CN202180075329.2A patent/CN116782866A/en active Pending
- 2021-12-02 WO PCT/JP2021/044343 patent/WO2022124201A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013121922A (en) * | 2011-12-09 | 2013-06-20 | Lion Corp | Sheet-like cosmetic |
JP2020105077A (en) * | 2018-12-26 | 2020-07-09 | クラシエホームプロダクツ株式会社 | Emulsion cosmetic |
JP2020132631A (en) * | 2019-02-15 | 2020-08-31 | ロート製薬株式会社 | External skin composition |
JP2020193154A (en) * | 2019-05-24 | 2020-12-03 | 株式会社マンダム | Sheet cosmetics |
Non-Patent Citations (1)
Title |
---|
DATABASE GNPD MINTEL; 22 October 2018 (2018-10-22), "Facial Sheet Mask", XP055940564, Database accession no. 6073303 * |
Also Published As
Publication number | Publication date |
---|---|
CN116782866A (en) | 2023-09-19 |
JP2022090804A (en) | 2022-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2696488C2 (en) | Elastic gelatinous composition | |
JP4608584B1 (en) | Skin preparation | |
JP7061062B2 (en) | Underwater oil type solid cosmetics | |
JP2005501022A (en) | Personal care composition comprising a polyol-in-silicone emulsion | |
JP3742984B2 (en) | Water-in-oil emulsion composition | |
JP2011178693A (en) | Beauty method | |
EP1576943B1 (en) | Cosmetic oil-in-water emulsion preparation | |
JP6392419B1 (en) | W / O emulsion | |
EP3357488A1 (en) | Cosmetic material | |
JP7472336B2 (en) | Cosmetics, cosmetics for warm use, and beauty method | |
JP2012067024A (en) | Skin care preparation for external use | |
WO2022124201A1 (en) | Sheet-like cosmetic | |
WO2007007250A1 (en) | Lipophilic personal care composition | |
US20070009457A1 (en) | Lipophilic personal care composition | |
JP2022090803A (en) | Skin cosmetic | |
JP6948341B2 (en) | Oily compositions and oily cosmetics | |
JP5132896B2 (en) | Transparent solid composition and transparent solid cosmetic containing the same as a base | |
US20210077364A1 (en) | Thick water-based cosmetic | |
JP7153028B2 (en) | Vesicle-containing composition | |
TW202203894A (en) | Oil-in-water type cosmetic emulsion preparation | |
JP3920797B2 (en) | Sheet-form external preparation for skin and method for producing the same | |
CN115151239B (en) | Oil-in-water emulsion composition | |
JP7433893B2 (en) | Oil-in-water emulsion composition | |
JP2005225771A (en) | Oil-in-water type emulsified composition | |
JP7077037B2 (en) | Thick composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21903305 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 202180075329.2 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21903305 Country of ref document: EP Kind code of ref document: A1 |